relation_type	source_name	source_type	source_id	target_name	target_type	target_id	key_sentence	pmids	resource
BioMedGPS::AssociatedWith::CellularComponent:Disease	mitochondria	CellularComponent	GO:0005739	ME/CFS	Disease	MONDO:0005404	"Due to the potential role that mitochondria may play in ME/CFS, mitochondrial-targeting nutraceutical interventions have been used to potentially assist in improving patient outcomes such as fatigue."	33596913	CustomKB
BioMedGPS::AssociatedWith::Metabolite:Disease	coenzyme A	Metabolite	HMDB:HMDB0001423	Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"They exhibited proteome alterations, including altered mitochondrial metabolism, centred on pyruvate dehydrogenase and coenzyme A metabolism, leading to a decreased capacity to provide adequate intracellular ATP levels."	34209852	CustomKB
BioMedGPS::AssociatedWith::Metabolite:Disease	intracellular ATP	Metabolite	HMDB:HMDB0000538	Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"They exhibited proteome alterations, including altered mitochondrial metabolism, centred on pyruvate dehydrogenase and coenzyme A metabolism, leading to a decreased capacity to provide adequate intracellular ATP levels."	34209852	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Metabolite	oxidative-redox stress	BiologicalProcess	GO:0006979	homocysteine	Metabolite	HMDB:HMDB0000742	"Importantly, elevated homocysteine may be considered a biomarker for impaired FOCM, which is known to result in increased oxidative-redox stress."	35056324	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Gene	Ca2+ influx	BiologicalProcess	GO:0070509	transient receptor potential melastatin 3 (TRPM3)	Gene	ENTREZ:80036	"Collectively, these findings validate that TRPM3 loss of function results in altered Ca2+ influx supporting the growing evidence that ME/CFS is a TRP ion channel disorder and that NTX provides a potential therapeutic intervention for ME/CFS."	35172836	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Gene	activation of microglia	BiologicalProcess	GO:0001774	TNF	Gene	ENTREZ:7124	The case is made that this shared chronicity arises from a positive feedback loop causing the persistence of the activation of microglia by the TNF that these cells generate.	35174650	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	O2 exchange	BiologicalProcess	GO:0072592	Long COVID	Disease	MONDO:0100233	"Although the symptoms of Long COVID are multifarious, we here argue that the ability of these fibrin amyloid microclots (fibrinaloids) to block up capillaries, and thus to limit the passage of red blood cells and hence O2 exchange, can actually underpin the majority of these symptoms."	35195253	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Anatomy	glutamate metabolism	BiologicalProcess	GO:0006536	brain	Anatomy	MESH:D001921	"Numerous altered pathways were observed to depend on glutamate metabolism, a crucial component of the homeostasis of many organs in the body, including the brain."	35358096	CustomKB
BioMedGPS::AssociatedWith::Metabolite:Symptom	glutamate	Metabolite	HMDB:HMDB0029163	Post-exertional malaise (PEM)	Symptom	SYMP:0019176	"Numerous altered pathways were observed to depend on glutamate metabolism, a crucial component of the homeostasis of many organs in the body, including the brain."	35358096	CustomKB
BioMedGPS::AssociatedWith::Gene:Symptom	hemoglobin	Gene	ENTREZ:3043	fatigue	Symptom	SYMP:0019177	"Patients exhibiting post-COVID fatigue at 6 or 12 months exhibited a lower hemoglobin level, higher lymphocyte count, and lower neutrophil and platelets counts (all, p < 0.05), whereas those exhibiting post-COVID dyspnea at 6 or 12 months had a lower platelet count and lower alanine transaminase, aspartate transaminase, and lactate dehydrogenase (LDH) levels (all, p < 0.05) than those not developing post-COVID fatigue or dyspnea, respectively."	35381597	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Symptom	lymphocyte	BiologicalProcess	GO:0046649	fatigue	Symptom	SYMP:0019177	"Patients exhibiting post-COVID fatigue at 6 or 12 months exhibited a lower hemoglobin level, higher lymphocyte count, and lower neutrophil and platelets counts (all, p < 0.05), whereas those exhibiting post-COVID dyspnea at 6 or 12 months had a lower platelet count and lower alanine transaminase, aspartate transaminase, and lactate dehydrogenase (LDH) levels (all, p < 0.05) than those not developing post-COVID fatigue or dyspnea, respectively."	35381597	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Symptom	neutrophil	BiologicalProcess	GO:0042119	fatigue	Symptom	SYMP:0019177	"Patients exhibiting post-COVID fatigue at 6 or 12 months exhibited a lower hemoglobin level, higher lymphocyte count, and lower neutrophil and platelets counts (all, p < 0.05), whereas those exhibiting post-COVID dyspnea at 6 or 12 months had a lower platelet count and lower alanine transaminase, aspartate transaminase, and lactate dehydrogenase (LDH) levels (all, p < 0.05) than those not developing post-COVID fatigue or dyspnea, respectively."	35381597	CustomKB
BioMedGPS::AssociatedWith::Gene:Symptom	alanine transaminase	Gene	ENTREZ:2875	dyspnea	Symptom	SYMP:0019153	"Patients exhibiting post-COVID fatigue at 6 or 12 months exhibited a lower hemoglobin level, higher lymphocyte count, and lower neutrophil and platelets counts (all, p < 0.05), whereas those exhibiting post-COVID dyspnea at 6 or 12 months had a lower platelet count and lower alanine transaminase, aspartate transaminase, and lactate dehydrogenase (LDH) levels (all, p < 0.05) than those not developing post-COVID fatigue or dyspnea, respectively."	35381597	CustomKB
BioMedGPS::AssociatedWith::Gene:Symptom	aspartate transaminase	Gene	ENTREZ:2805	dyspnea	Symptom	SYMP:0019153	"Patients exhibiting post-COVID fatigue at 6 or 12 months exhibited a lower hemoglobin level, higher lymphocyte count, and lower neutrophil and platelets counts (all, p < 0.05), whereas those exhibiting post-COVID dyspnea at 6 or 12 months had a lower platelet count and lower alanine transaminase, aspartate transaminase, and lactate dehydrogenase (LDH) levels (all, p < 0.05) than those not developing post-COVID fatigue or dyspnea, respectively."	35381597	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Compound	Extracellular vesicles (EVs)	BiologicalProcess	GO:0140112	phosphatidylserine (PS)	Compound	MESH:D010718	"Furthermore, EVs express tissue factor and phosphatidylserine (PS) which aggravate thrombosis."	35449732	CustomKB
BioMedGPS::AssociatedWith::Metabolite:BiologicalProcess	glucose	Metabolite	HMDB:HMDB0000122	immunosuppression	BiologicalProcess	GO:0002683	"This immunosuppression, along with observed enhancement of compensatory antibody responses to counter the microbial translocation, was associated with and may be mediated by alterations in glucose and citrate metabolism and an IL-10 immunoregulatory response."	37396339	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Compound	Natural Killer cells	BiologicalProcess	GO:0002228	fatty acids	Compound	MESH:D005227	"We examined samples obtained from at least 8 and as many as 20 subjects for immune cell fatty acid characterization in a variety of experiments and found that all three isolated cell types increased their utilization of lipids and levels of pertinent proteins involved in this metabolic pathway in ME/CFS samples, particularly during higher energy demands and activation."	36768336	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Compound	CD4+ T cells	BiologicalProcess	GO:0035710	fatty acids	Compound	MESH:D005227	"We examined samples obtained from at least 8 and as many as 20 subjects for immune cell fatty acid characterization in a variety of experiments and found that all three isolated cell types increased their utilization of lipids and levels of pertinent proteins involved in this metabolic pathway in ME/CFS samples, particularly during higher energy demands and activation."	36768336	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Compound	CD8+ T cells	BiologicalProcess	GO:0035710	fatty acids	Compound	MESH:D005227	"We examined samples obtained from at least 8 and as many as 20 subjects for immune cell fatty acid characterization in a variety of experiments and found that all three isolated cell types increased their utilization of lipids and levels of pertinent proteins involved in this metabolic pathway in ME/CFS samples, particularly during higher energy demands and activation."	36768336	CustomKB
BioMedGPS::AssociatedWith::Gene:BiologicalProcess	ATG13	Gene	ENTREZ:9776	observed stress response in microglial cells	BiologicalProcess	GO:0002282	"ME/CFS patients evoke the production of reactive oxygen species (ROS) and nitric oxide in human HMC3 microglial cells, whereas neutralization of ATG13 strongly diminishes the production of ROS and NO, suggesting that ATG13 plays a role in the observed stress response in microglial cells."	35487443	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	cerebral blood flow	BiologicalProcess	GO:0120275	post-acute sequelae COVID	Disease	MONDO:0100233	"Because the two key features - post exertional malaise and decreased cerebral blood flow - are also recognized in a subset of patients with post-acute sequelae COVID, we suggest that our findings may also be pertinent to this entity."	35614970	CustomKB
BioMedGPS::AssociatedWith::Pathway:Metabolite	kynurenine pathway (KP)	Pathway	KEGG:hsa00380	nicotinamide adenine dinucleotide (NAD+)	Metabolite	HMDB:HMDB0002012	"Hyperactivation of the KP, whether compensatory or a driving mechanism of degeneration can limit the availability of NAD+ and exacerbate the symptoms of ME/CFS."	35656104	CustomKB
BioMedGPS::AssociatedWith::Pathway:Disease	kynurenine pathway (KP)	Pathway	KEGG:hsa00380	ME/CFS	Disease	MONDO:0005404	"Hyperactivation of the KP, whether compensatory or a driving mechanism of degeneration can limit the availability of NAD+ and exacerbate the symptoms of ME/CFS."	35656104	CustomKB
BioMedGPS::AssociatedWith::Disease:Compound	ME/CFS	Disease	MONDO:0005404	plasmalogen	Compound	MESH:D010955	"Along with the promising outcomes of plasmalogen replacement therapy (PRT) for various neurodegenerative/neuropsychiatric disorders, we sought to propose PRT as a simple, effective, and safe strategy for the potential relief of the debilitating symptoms associated with ME/CFS and post-COVID-19 syndrome."	37423295	CustomKB
BioMedGPS::AssociatedWith::Disease:Compound	post-COVID-19	Disease	MONDO:0100233	plasmalogen	Compound	MESH:C022403	"Along with the promising outcomes of plasmalogen replacement therapy (PRT) for various neurodegenerative/neuropsychiatric disorders, we sought to propose PRT as a simple, effective, and safe strategy for the potential relief of the debilitating symptoms associated with ME/CFS and post-COVID-19 syndrome."	37423295	CustomKB
BioMedGPS::AssociatedWith::Pathway:Metabolite	kynurenine pathway	Pathway	KEGG:hsa00380	nicotinamide adenine dinucleotide (NADH)	Metabolite	HMDB:HMDB0001487	KP plays a central role in cellular energy production through the production of nicotinamide adenine dinucleotide (NADH).	35821534	CustomKB
BioMedGPS::AssociatedWith::Pathway:BiologicalProcess	kynurenine pathway	Pathway	KEGG:hsa00380	immune response	BiologicalProcess	GO:0006955	"In addition, this pathway has been shown to mediate immune response and neuroinflammation through its metabolites. This review, we will discuss the pathology and management of ME/CFS and provide evidence pertaining KP abnormalities and symptoms that are classic characteristics of ME/CFS."	35821534	CustomKB
BioMedGPS::AssociatedWith::Pathway:Symptom	kynurenine pathway	Pathway	KEGG:hsa00380	neuroinflammation	Symptom	MESH:D020078	"In addition, this pathway has been shown to mediate immune response and neuroinflammation through its metabolites. This review, we will discuss the pathology and management of ME/CFS and provide evidence pertaining KP abnormalities and symptoms that are classic characteristics of ME/CFS."	35821534	CustomKB
BioMedGPS::AssociatedWith::Pathway:Disease	Tryptophan catabolism	Pathway	REACT:R-HSA-71240	chronic fatigue syndrome	Disease	MONDO:0005404	"Hyperactivation of the kynurenine pathway, which is the main catabolic route for tryptophan, whether compensatory or a driving mechanism of degeneration can limit the availability of NAD+ and exacerbate the symptoms of ME/CFS."	35656104	CustomKB
BioMedGPS::AssociatedWith::Compound:Disease	ATP	Compound	DrugBank:DB00171	chronic fatigue syndrome	Disease	MONDO:0005404	"Evidence suggests that problems generating and using the main energy molecule, adenosine triphosphate (ATP), may be a fundamental driver of ME/CFS."	34454716	CustomKB
BioMedGPS::AssociatedWith::Compound:Disease	Lactic acid	Compound	DrugBank:DB04398	chronic fatigue syndrome	Disease	MONDO:0005404	"Other studies have reported high levels of lactate, or increased acidosis in the blood, cerebrospinal fluid, and muscles."	34454716	CustomKB
BioMedGPS::AssociatedWith::Compound:Disease	Interleukin-10	Compound	DrugBank:DB12880	chronic fatigue syndrome	Disease	MONDO:0005404	"increased complement split products, oxidative stress, and gene expression of interleukin-10."	34454716	CustomKB
BioMedGPS::AssociatedWith::Symptom:Disease	Sleep Disorders	Symptom	SYMP:0000566	chronic fatigue syndrome	Disease	MONDO:0005404	"Patients experience various sleep disturbances, such as problems in falling or staying asleep."	34454716	CustomKB
BioMedGPS::AssociatedWith::Symptom:Disease	Memory Disorders	Symptom	SYMP:0000719	chronic fatigue syndrome	Disease	MONDO:0005404	"Other abnormalities include decreased reaction time, working memory, and attention."	34454716	CustomKB
BioMedGPS::AssociatedWith::Disease:BiologicalProcess	Chronic Fatigue Syndrome (CFS/ME)	Disease	MONDO:0005404	NK-cells	BiologicalProcess	GO:0039671	"Transfecting primary NK cells with hsa-miR-99b or hsa-miR-330-3p, resulted in gene expression changes consistent with NK cell activation but diminished cytotoxicity, suggesting that defective NK cell function contributes to CFS/ME pathology."	26967895	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Gene	impairment of autophagy	BiologicalProcess	GO:0010507	ATG13	Gene	ENTREZ:9776	"ME/CFS patients evoke the production of reactive oxygen species (ROS) and nitric oxide in human HMC3 microglial cells, whereas neutralization of ATG13 strongly diminishes the production of ROS and NO, suggesting that ATG13 plays a role in the observed stress response in microglial cells."	35487443	CustomKB
BioMedGPS::AssociatedWith::Anatomy:Compound	epipharyngeal mucosa	Anatomy	MESH:D009305	zinc chloride	Compound	DrugBank:DB14533	These results suggest that EAT has potential as a novel method for long COVID treatment.	35632649	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	immunoglobulin levels	BiologicalProcess	GO:0048305	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)	Disease	MONDO:0005404	"Immune dysregulation in ME/CFS has been frequently described including changes in cytokine profiles and immunoglobulin levels, T- and B-cell phenotype and a decrease of natural killer cell cytotoxicity."	29635081	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	changes in cytokine profiles	BiologicalProcess	GO:0000910	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)	Disease	MONDO:0005404	"Immune dysregulation in ME/CFS has been frequently described including changes in cytokine profiles and immunoglobulin levels, T- and B-cell phenotype and a decrease of natural killer cell cytotoxicity."	29635081	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	T- and B-cell phenotype	BiologicalProcess	GO:0036166	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)	Disease	MONDO:0005404	"Immune dysregulation in ME/CFS has been frequently described including changes in cytokine profiles and immunoglobulin levels, T- and B-cell phenotype and a decrease of natural killer cell cytotoxicity."	29635081	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	natural killer cell cytotoxicity	BiologicalProcess	GO:0002728	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)	Disease	MONDO:0005404	"Immune dysregulation in ME/CFS has been frequently described including changes in cytokine profiles and immunoglobulin levels, T- and B-cell phenotype and a decrease of natural killer cell cytotoxicity."	29635081	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:BiologicalProcess	mitochondrial membrane potential	BiologicalProcess	GO:0010917	CD8+ T cell	BiologicalProcess	GO:0036037	"Both CD4+ and CD8+ T cells from patients with ME/CFS had reduced glycolysis at rest, whereas CD8+ T cells also had reduced glycolysis following activation."	31830003	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Compound	DNA methylation modifications	BiologicalProcess	GO:0006306	glucocorticoid	Compound	MESH:D005938	"Among ME/CFS patients, glucocorticoid sensitivity was associated with differential methylation at 13 loci."	28231836	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	NK cytotoxic activity	BiologicalProcess	GO:0051132	CFS/ME	Disease	MONDO:0005404	"Furthermore, NK cytotoxic activity may be a suitable biomarker for diagnosing CFS/ME as it was consistently decreased during the course of the 12 months study."	22571715	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	regulatory T (Tregs)	BiologicalProcess	GO:0032834	Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)	Disease	MONDO:0005404	We observed a significant increase in Tregs in the CFS/ME group (p≤0.05) compared to the healthy control group.	27001659	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	invariant Natural Killer T (iNKT)	BiologicalProcess	GO:0030101	Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)	Disease	MONDO:0005404	"Conversely, CD4+iNKT percentage of iNKT, was significantly increased in the CFS/ME group compared with healthy controls and the double-negative iNKT percentage of iNKT significantly decreased compared with the healthy control group."	27001659	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	redox status	BiologicalProcess	GO:0009455	ME/CFS	Disease	MONDO:0005404	"In ME/CFS patients, severe alterations of the muscle excitability, the redox status, as well as the CD26-expression level are correlated with a marked impairment of the quality-of-life."	27580693	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	hypothalamic-pituitary-adrenal (HPA) axis function	BiologicalProcess	GO:0006950	ME/CFS	Disease	MONDO:0005404	"Our results indicate DNA methylation modifications in cellular metabolism in ME/CFS despite a heterogeneous patient population, implicating these processes in immune and HPA axis dysfunction in ME/CFS."	28231836	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	hyperosmotic stress	BiologicalProcess	GO:0006972	ME/CFS	Disease	MONDO:0005404	We believe the observed robust impedance modulation difference of the samples in response to hyperosmotic stress can potentially provide us with a unique indicator of ME/CFS.	31036648	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	NK cell cytotoxicity	BiologicalProcess	GO:0042267	ME/CFS	Disease	MONDO:0005404	"A consistent finding among all papers included in this review was impaired NK cell cytotoxicity, suggesting that it is a reliable and appropriate cellular model for continued research in ME/CFS patients."	31727160	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	CD8+ T cell	BiologicalProcess	GO:0036037	ME/CFS	Disease	MONDO:0005404	We found that ME/CFS CD8+ T cells had reduced mitochondrial membrane potential compared with those from healthy controls.	31830003	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	extracellular vesicles (EVs)	BiologicalProcess	GO:0140112	ME/CFS	Disease	MONDO:0005404	"Our results show that routine creatine kinase (CK) blood values, plasma EVs physical characteristics (including counts, size and zeta-potential), and a limited number of differentially expressed PBMC and EV miRNAs appear significantly associated with severe ME/CFS (p < 0.05)."	32034172	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	chronic fatigue syndrome/myalgic encephalomyelitis (ME/CFS)	Disease	MONDO:0005404	cerebral blood flow (CBF)	BiologicalProcess	GO:0120275	"During HUT, extracranial Doppler measurements demonstrate that CBF is reduced in ME/CFS patients with POTS, dOH, and even in those without HR/BP abnormalities."	32140630	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	cerebral blood flow (CBF)	BiologicalProcess	GO:0120275	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	Using a less demanding 20 degree tilt test for 15 min in severe ME/CFS patients resulted in a mean CBF decline of 27%.	32545797	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	long-haul COVID-19	Disease	MONDO:0100233	cerebral blood flow	BiologicalProcess	GO:0120275	The cerebral blood flow reduction was larger in the long-haul COVID-19 patients compared with the ME/CFS patients with a normal heart rate and blood pressure response.	35056336	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	ME/CFS	Disease	MONDO:0005404	Cerebral blood flow	BiologicalProcess	GO:0120275	Cerebral blood flow and cardiac index reductions during tilt were more severely impaired than in many patients with ME/CFS.	35056336	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	TRPM3-dependent Ca2+ influx	BiologicalProcess	GO:0070509	ME/CFS	Disease	MONDO:0005404	TRPM3-dependent Ca2+ influx was restored in ME/CFS patients following overnight treatment of isolated NK cells with NTX in vitro.	35172836	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	activation of microglia	BiologicalProcess	GO:0001774	long COVID-19	Disease	MONDO:0100233	The case is made that this shared chronicity arises from a positive feedback loop causing the persistence of the activation of microglia by the TNF that these cells generate.	35174650	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	platelet aggregation	BiologicalProcess	GO:0070527	ME/CFS	Disease	MONDO:0005404	"Lastly, we observed a slight increase in platelet aggregation in stimulated cells, suggestive of a possible role of platelet activity in ME/CFS pathophysiology and disease severity."	35943990	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	apoptotic and necrotic cell death in T cells	BiologicalProcess	GO:0006924	ME/CFS	Disease	MONDO:0005404	TEM analysis of CD3/CD28-stimulated T cells suggested a significant increase in the levels of apoptotic and necrotic cell death in T cells from ME/CFS patients (over 2-fold).	35943990	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	lipid storage	BiologicalProcess	GO:0019915	ME/CFS	Disease	MONDO:0005404	We also found a large increase in intracellular giant lipid droplet-like organelles in the stimulated PBMCs from the extremely severe ME/CFS patient potentially indicative of a lipid storage disorder.	35943990	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	CD4+iNKT	BiologicalProcess	GO:0045224	Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)	Disease	MONDO:0005404	"CD4+iNKT percentage of iNKT, was significantly increased in the CFS/ME group compared with healthy controls and the double-negative iNKT percentage of iNKT significantly decreased compared with the healthy control group."	27001659	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	CD8(-)CD4(-)	BiologicalProcess	GO:0043369	CFS/ME	Disease	MONDO:0005404	"Naïve CD8(+)T cells, CD8(-)CD4(-) and CD56(-)CD16(-) iNKT phenotypes, γδ2T cells and effector memory subsets were significantly increased in severe CFS/ME patients at 6 months."	26370228	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	terminally differentiated effector CD8+ T cell	BiologicalProcess	GO:0043374	ME/CFS	Disease	MONDO:0005404	"In contrast, the T cell compartment was altered in ME/CFS, with increased proportions of effector memory CD8+ T cells and decreased proportions of terminally differentiated effector CD8+ T cells."	31057538	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	mucosal associated invariant T cells (MAIT) cell	BiologicalProcess	GO:0002403	ME/CFS	Disease	MONDO:0005404	"Conversely, there was a significantly increased proportion of mucosal associated invariant T cells (MAIT) cells, especially in severely affected ME/CFS patients."	31057538	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	effector memory CD8+ T cell	BiologicalProcess	GO:0035709	ME/CFS	Disease	MONDO:0005404	"In contrast, the T cell compartment was altered in ME/CFS, with increased proportions of effector memory CD8+ T cells and decreased proportions of terminally differentiated effector CD8+ T cells."	31057538	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	nitrosative stress	BiologicalProcess	GO:0051409	ME/CFS	Disease	MONDO:0005404	"Such abnormalities include extensive data showing that at least a subgroup has a pro-inflammatory state, increased oxidative and nitrosative stress, disruption of gut mucosal barriers and mitochondrial dysfunction together with dysregulated bioenergetics."	31509764	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	oxidative	BiologicalProcess	GO:0006979	ME/CFS	Disease	MONDO:0005404	"Such abnormalities include extensive data showing that at least a subgroup has a pro-inflammatory state, increased oxidative and nitrosative stress, disruption of gut mucosal barriers and mitochondrial dysfunction together with dysregulated bioenergetics."	31509764	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	cerebral blood flow	BiologicalProcess	GO:0120275	Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"Overall, controls had higher BOLD signals suggesting reduced global cerebral blood flow in ME/CFS."	34975370	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	cerebral blood flow (CBF)	BiologicalProcess	GO:0120275	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"In ME/CFS patients with orthostatic intolerance symptoms, cardiac output and CBF are significantly reduced during a tilt test."	35056360	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Disease	innate immune response	BiologicalProcess	GO:0045087	ME/CFS	Disease	MONDO:0005404	"Relying on data from two independent pairs of ME/CFS and control cohorts, one at rest and one undergoing an exercise challenge, we identify a state of suppressed acute-phase innate immune response to microbial translocation in conjunction with a compromised gut epithelium in ME/CFS."	37396339	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Symptom	orthostatic intolerance	Symptom	MESH:D054971	cerebral blood flow (CBF)	BiologicalProcess	GO:0120275	"This study shows that orthostatic intolerance symptoms are related to CBF reduction, and that the majority of ME/CFS patients (90%) show an abnormal cerebral flow reduction during orthostatic stress testing."	32140630	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Symptom	glutamate metabolism	BiologicalProcess	GO:0006536	Post-exertional malaise (PEM)	Symptom	SYMP:0019176	"Numerous altered pathways were observed to depend on glutamate metabolism, a crucial component of the homeostasis of many organs in the body, including the brain."	35358096	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Symptom	platelet	BiologicalProcess	GO:0030168	dyspnea	Symptom	SYMP:0019153	"The multivariate regression analyses revealed that a lower platelet count and lower LDH levels were associated but just explaining 4.5% of the variance, of suffering from post-COVID fatigue and dyspnea, respectively."	35381597	CustomKB
BioMedGPS::AssociatedWith::BiologicalProcess:Symptom	platelet	BiologicalProcess	GO:0030168	fatigue	Symptom	SYMP:0019177	"The multivariate regression analyses revealed that a lower platelet count and lower LDH levels were associated but just explaining 4.5% of the variance, of suffering from post-COVID fatigue and dyspnea, respectively."	35381597	CustomKB
BioMedGPS::AssociatedWith::CellularComponent:Disease	extracellular vesicles (EVs)	CellularComponent	GO:1903561	CFS/ME	Disease	MONDO:0005404	These findings provide preliminary evidence that blood-derived EVs may distinguish CFS/ME patients from HCs.	29696075	CustomKB
BioMedGPS::AssociatedWith::Compound:Disease	TBARS	Compound	MESH:D017392	Myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"the LHS score was negatively correlated with the exercise-induced TBARS increase and positively correlated with CD26-expression while the pain component of SF-36 was negatively correlated with CD26-expression; (4) the TBARS increase and the M-wave decrease were the highest, and the CD26-expression level the lowest in patients who had been submitted to infectious stressors."	27580693	CustomKB
BioMedGPS::AssociatedWith::Compound:Disease	glucocorticoids	Compound	MESH:D005938	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)	Disease	MONDO:0005404	"We detected 12,608 differentially methylated sites between ME/CFS patients and healthy controls predominantly localized to cellular metabolism genes, some of which were also related to self-reported quality of life health scores. Among ME/CFS patients, glucocorticoid sensitivity was associated with differential methylation at 13 loci."	28231836	CustomKB
BioMedGPS::AssociatedWith::Gene:Symptom	fatigue	Symptom	SYMP:0019177	WASF3	Gene	ENTREZ:10810	"In particular, the gene WASF3 (aka WAVE3) possibly regulates brain cytokines involved in the mechanism of fatigue through the p38 MAPK regulatory pathway."	21584188	CustomKB
BioMedGPS::AssociatedWith::Gene:Symptom	CXCL9 (MIG)	Gene	ENTREZ:4283	fatigue	Symptom	MESH:D005221	Only CXCL9 (MIG) inversely correlated with fatigue duration.	28760971	CustomKB
BioMedGPS::AssociatedWith::Gene:Symptom	lactate dehydrogenase (LDH)	Gene	ENTREZ:3939	fatigue	Symptom	SYMP:0019177	"The multivariate regression analyses revealed that a lower platelet count and lower LDH levels were associated but just explaining 4.5% of the variance, of suffering from post-COVID fatigue and dyspnea, respectively."	35381597	CustomKB
BioMedGPS::AssociatedWith::Gene:Symptom	lactate dehydrogenase (LDH)	Gene	ENTREZ:3939	dyspnea	Symptom	SYMP:0019153	"The multivariate regression analyses revealed that a lower platelet count and lower LDH levels were associated but just explaining 4.5% of the variance, of suffering from post-COVID fatigue and dyspnea, respectively."	35381597	CustomKB
BioMedGPS::AssociatedWith::Metabolite:Disease	pyruvate	Metabolite	HMDB:HMDB0254610	Chronic fatigue syndrome (CFS)	Disease	MONDO:0005404	"The combination of ornithine/citrulline and pyruvate/isocitrate ratios discriminated CFS patients from healthy controls, yielding area under the receiver operating characteristic curve values of 0.801 (95% confidential interval [CI]: 0.711-0.890, P < 0.0001) and 0.750 (95% CI: 0.584-0.916, P = 0.0069) for training (n = 93) and validation (n = 40) datasets, respectively."	27725700	CustomKB
BioMedGPS::AssociatedWith::Metabolite:Pathway	homocysteine	Metabolite	HMDB:HMDB0000742	folate-mediated one-carbon metabolism (FOCM)	Pathway	KEGG:hsa01200	"Importantly, elevated homocysteine may be considered a biomarker for impaired FOCM, which is known to result in increased oxidative-redox stress."	35056324	CustomKB
BioMedGPS::AssociatedWith::MolecularFunction:Symptom	histamine	MolecularFunction	GO:0031964	allergic	Symptom	SYMP:0000900	"These include neuromuscular limitations that could be treated with manual forms of therapy, orthostatic intolerance and POTS for which there are multiple medications and non-pharmacologic therapies, treatable allergic and mast cell phenomena, and neurologic abnormalities that may require specific treatment."	33996867	CustomKB
BioMedGPS::AssociatedWith::Pathway:BiologicalProcess	glycolysis	Pathway	KEGG:hsa00010	CD8+ T cell	BiologicalProcess	GO:0036037	"Both CD4+ and CD8+ T cells from patients with ME/CFS had reduced glycolysis at rest, whereas CD8+ T cells also had reduced glycolysis following activation."	31830003	CustomKB
BioMedGPS::AssociatedWith::Pathway:Disease	sphingolipid	Pathway	KEGG:hsa00600	CFS	Disease	MONDO:0005404	Patients with CFS showed abnormalities in 20 metabolic pathways.	27573827	CustomKB
BioMedGPS::AssociatedWith::Pathway:Disease	phospholipid	Pathway	KEGG:hsa00564	CFS	Disease	MONDO:0005404	Patients with CFS showed abnormalities in 20 metabolic pathways.	27573827	CustomKB
BioMedGPS::AssociatedWith::Pathway:Disease	cholesterol	Pathway	REACT:R-HSA-191273	CFS	Disease	MONDO:0005404	Patients with CFS showed abnormalities in 20 metabolic pathways.	27573827	CustomKB
BioMedGPS::AssociatedWith::Pathway:Disease	purine	Pathway	KEGG:hsa00230	CFS	Disease	MONDO:0005404	Patients with CFS showed abnormalities in 20 metabolic pathways.	27573827	CustomKB
BioMedGPS::AssociatedWith::Pathway:Disease	pyrroline-5-carboxylate	Pathway	KEGG:hsa_M00015	CFS	Disease	MONDO:0005404	Patients with CFS showed abnormalities in 20 metabolic pathways.	27573827	CustomKB
BioMedGPS::AssociatedWith::Pathway:Disease	riboflavin	Pathway	KEGG:hsa00740	CFS	Disease	MONDO:0005404	Patients with CFS showed abnormalities in 20 metabolic pathways.	27573827	CustomKB
BioMedGPS::AssociatedWith::Pathway:Disease	mitochondrial metabolism	Pathway	REACT:R-HSA-1592230	CFS	Disease	MONDO:0005404	Patients with CFS showed abnormalities in 20 metabolic pathways.	27573827	CustomKB
BioMedGPS::AssociatedWith::Pathway:Disease	branch chain amino acid	Pathway	KEGG:hsa00290	CFS	Disease	MONDO:0005404	Patients with CFS showed abnormalities in 20 metabolic pathways.	27573827	CustomKB
BioMedGPS::AssociatedWith::Pathway:Disease	peroxisomal	Pathway	REACT:R-HSA-390918	CFS	Disease	MONDO:0005404	Patients with CFS showed abnormalities in 20 metabolic pathways.	27573827	CustomKB
BioMedGPS::AssociatedWith::Pathway:Disease	tricarboxylic acid (TCA)	Pathway	KEGG:hsa00020	CFS	Disease	MONDO:0005404	CFS patients exhibited significant differences in intermediate metabolite concentrations in the tricarboxylic acid (TCA) and urea cycles.	27725700	CustomKB
BioMedGPS::AssociatedWith::Pathway:Disease	urea cycles	Pathway	KEGG:hsa00020	CFS	Disease	MONDO:0005404	CFS patients exhibited significant differences in intermediate metabolite concentrations in the tricarboxylic acid (TCA) and urea cycles.	27725700	CustomKB
BioMedGPS::AssociatedWith::Pathway:Disease	kynurenine pathway	Pathway	KEGG:hsa00380	ME/CFS	Disease	MONDO:0005404	"In addition, this pathway has been shown to mediate immune response and neuroinflammation through its metabolites. This review, we will discuss the pathology and management of ME/CFS and provide evidence pertaining KP abnormalities and symptoms that are classic characteristics of ME/CFS."	35821534	CustomKB
BioMedGPS::AssociatedWith::Pathway:Disease	sphingolipid	Pathway	REACT:R-MMU-428157	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"Patients with CFS showed abnormalities in 20 metabolic pathways. Eighty percent of the diagnostic metabolites were decreased, consistent with a hypometabolic syndrome. Pathway abnormalities included sphingolipid, phospholipid, purine, cholesterol, microbiome, pyrroline-5-carboxylate, riboflavin, branch chain amino acid, peroxisomal, and mitochondrial metabolism."	27573827	CustomKB
BioMedGPS::biomarker::Metabolite:Disease	ornithine/citrulline	Metabolite	HMDB:HMDB0000214	CFS	Disease	MONDO:0005404	The combination of ornithine/citrulline and pyruvate/isocitrate ratios discriminated CFS patients from healthy controls	27725700	CustomKB
BioMedGPS::biomarker::Metabolite:Disease	pyruvate/isocitrate	Metabolite	HMDB:HMDB0011111	CFS	Disease	MONDO:0005404	The combination of ornithine/citrulline and pyruvate/isocitrate ratios discriminated CFS patients from healthy controls	27725700	CustomKB
BioMedGPS::biomarker::Metabolite:Disease	ornithine	Metabolite	HMDB:HMDB0000214	CFS	Disease	MONDO:0005404	The combination of ornithine/citrulline and pyruvate/isocitrate ratios discriminated CFS patients from healthy controls	27725700	CustomKB
BioMedGPS::biomarker::Metabolite:Disease	pyruvate	Metabolite	HMDB:HMDB0011111	CFS	Disease	MONDO:0005404	The combination of ornithine/citrulline and pyruvate/isocitrate ratios discriminated CFS patients from healthy controls	27725700	CustomKB
BioMedGPS::biomarker::Metabolite:Disease	citrulline	Metabolite	HMDB:HMDB0000904	CFS	Disease	MONDO:0005404	The combination of ornithine/citrulline and pyruvate/isocitrate ratios discriminated CFS patients from healthy controls	27725700	CustomKB
BioMedGPS::biomarker::Metabolite:Disease	isocitrate	Metabolite	HMDB:HMDB0304324	CFS	Disease	MONDO:0005404	The combination of ornithine/citrulline and pyruvate/isocitrate ratios discriminated CFS patients from healthy controls	27725700	CustomKB
BioMedGPS::E-::Compound:Gene	reactive oxygen species (ROS)	Compound	MESH:D017382	ATG13	Gene	ENTREZ:9776	"ME/CFS patients evoke the production of reactive oxygen species (ROS) and nitric oxide in human HMC3 microglial cells, whereas neutralization of ATG13 strongly diminishes the production of ROS and NO, suggesting that ATG13 plays a role in the observed stress response in microglial cells."	35487443	CustomKB
BioMedGPS::E-::Compound:Gene	nitric oxide	Compound	DrugBank:DB00435	ATG13	Gene	ENTREZ:9776	"ME/CFS patients evoke the production of reactive oxygen species (ROS) and nitric oxide in human HMC3 microglial cells, whereas neutralization of ATG13 strongly diminishes the production of ROS and NO, suggesting that ATG13 plays a role in the observed stress response in microglial cells."	35487443	CustomKB
BioMedGPS::E-::Disease:Gene	circulating interleukin (IL)-16	Gene	ENTREZ:3603	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"We observed highly significant reductions in the concentration of circulating interleukin (IL)-16, IL-7, and Vascular Endothelial Growth Factor A (VEGF-A) in ME/CFS patients."	26615570	CustomKB
BioMedGPS::E-::Disease:Gene	IL-10	Gene	ENTREZ:3586	CFS/ME	Disease	MONDO:0005404	"A significant decrease was observed at T2 in the CFS/ME group for IL-10 and IL-17A while at T3, IL-2 was increased in the CFS/ME group in comparison to the non-fatigued controls."	22571715	CustomKB
DGIDB::ALLOSTERIC MODULATOR::Gene:Compound	CXCL8	Gene	ENTREZ:3576	Dexamethasone	Compound	DrugBank:DB01234	The results showed that phorbol 12-myristate 13-acetate (CTD 00006852) and dexamethasone (CTD 00005779) are the two drug molecules that interacted with most genes.	36189286	CustomKB
DRUGBANK::treats::Compound:Disease	valacyclovir	Compound	DrugBank:DB00577	CFS	Disease	MONDO:0005404	CFS patients were treated with valacyclovir (14.3 mg/kg q6h) for ≥ 12 months.	23155374	CustomKB
DRUGBANK::treats::Compound:Disease	water-soluble B vitamins	Compound	MESH:D014803	folate-mediated one-carbon metabolism (FOCM)	Pathway	KEGG:hsa01200	It is hoped that this review will allow the reader to better understand the role of FOCM in the development and treatment of clinical disease states that may be associated with impaired FOCM and how to restore a more normal functional role for FOCM through improved nutrition and/or restoring the essential water-soluble B vitamins through oral supplementation.	35056324	CustomKB
DRUGBANK::treats::Compound:Disease	Naltrexone hydrochloride (NTX)	Compound	DrugBank:DB00704	TRPM3-dependent Ca2+ influx	BiologicalProcess	GO:0070509	TRPM3-dependent Ca2+ influx was restored in ME/CFS patients following overnight treatment of isolated NK cells with NTX in vitro.	35172836	CustomKB
DRUGBANK::treats::Compound:Disease	nicotinamide adenine dinucleotide (NAD+)	Metabolite	HMDB:HMDB0002012	Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"Hyperactivation of the KP, whether compensatory or a driving mechanism of degeneration can limit the availability of NAD+ and exacerbate the symptoms of ME/CFS."	35656104	CustomKB
DRUGBANK::treats::Compound:Disease	anhydrous enol oxaloacetate	Compound	DrugBank:DB02637	physical and metal fatigue	Symptom	SYMP:0019177	Significant reductions in physical and metal fatigue for ME/CFS and Long-COVID patients were seen after 6 weeks of treatment.	35764955	CustomKB
DRUGBANK::treats::Compound:Disease	B-cell depletion with rituximab	Compound	DrugBank:DB00073	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)	Disease	MONDO:0005404	"Consistently, clinical trials from Norway have shown that B-cell depletion with rituximab results in clinical benefits in about half of ME/CFS patients."	29635081	CustomKB
GNBR::A-::Compound:Gene	etanercept	Compound	DrugBank:DB00005	TNF	Gene	ENTREZ:7124	"While too large to negotiate the blood-brain barrier effectively, the specific anti-TNF biological, etanercept, shows promise when administered by the perispinal route, which allows it to bypass this obstruction."	35174650	CustomKB
GNBR::J::Compound:Disease	Aflatoxin (AF)	Compound	MESH:C012170	Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"Mold distributions (OTA, AF, and GT) in the urinalysis all demonstrated right skewness, while the distribution of age of ME/CFS patients diagnosed showed no deviation from normality."	35206241	CustomKB
GNBR::J::Compound:Disease	Ochratoxin A (OTA)	Compound	MESH:C025589	Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"Mold distributions (OTA, AF, and GT) in the urinalysis all demonstrated right skewness, while the distribution of age of ME/CFS patients diagnosed showed no deviation from normality."	35206241	CustomKB
GNBR::J::Compound:Disease	Gliotoxin (GT)	Compound	MESH:D005912	Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"Mold distributions (OTA, AF, and GT) in the urinalysis all demonstrated right skewness, while the distribution of age of ME/CFS patients diagnosed showed no deviation from normality."	35206241	CustomKB
GNBR::J::Compound:Disease	reactive oxygen species (ROS)	Compound	MESH:D017382	ME/CFS	Disease	MONDO:0005404	"ME/CFS patients evoke the production of reactive oxygen species (ROS) and nitric oxide in human HMC3 microglial cells, whereas neutralization of ATG13 strongly diminishes the production of ROS and NO, suggesting that ATG13 plays a role in the observed stress response in microglial cells."	35487443	CustomKB
GNBR::J::Compound:Disease	nitric oxide	Compound	DrugBank:DB00435	ME/CFS	Disease	MONDO:0005404	"ME/CFS patients evoke the production of reactive oxygen species (ROS) and nitric oxide in human HMC3 microglial cells, whereas neutralization of ATG13 strongly diminishes the production of ROS and NO, suggesting that ATG13 plays a role in the observed stress response in microglial cells."	35487443	CustomKB
GNBR::J::Compound:Disease	long COVID	Disease	MONDO:0100233	Inhibitor of P38 Kinase	Compound	DrugBank:DB01953	"Here, we propose a description of the pathophysiology of the Long COVID presentation based on inflammatory cytokine cascades and the p38 MAP kinase signaling pathways that regulate cytokine production."	37064029	CustomKB
GNBR::J::Compound:Disease	Hyperhomocysteinemia	Disease	MONDO:0004743	Homocysteine	Compound	DrugBank:DB04422	 Long COVID may be associated with an elevation of the biomarker homocysteine(Hcy) with resulting hyperhomocysteinemia (HHcy).	35056324	CustomKB
GNBR::J::Compound:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	Vitamin E	Compound	DrugBank:DB00163	" In relation to the long COVID-19 problem, it was reported that a low level of serum alpha-tocopherol(Vitamin E) improved during the remission phase, as compared to the exacerbation phase, in patients with chronic fatigue syndrome."	35454144	CustomKB
GNBR::J::Compound:Disease	long COVID	Disease	MONDO:0100233	Vitamin E	Compound	DrugBank:DB00163	" In relation to the long COVID-19 problem, it was reported that a low level of serum alpha-tocopherol(Vitamin E) improved during the remission phase, as compared to the exacerbation phase, in patients with chronic fatigue syndrome."	35454144	CustomKB
GNBR::J::Compound:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	Magnesium	Compound	DrugBank:DB14513	Latent magnesium deficiency is associated with myalgic encephalomyelitis/chronic fatigue syndrome(ME/CFS).	35454144	CustomKB
GNBR::J::Gene:Disease	COVID-19	Disease	MONDO:0100096	S100A12	Gene	ENTREZ:6283	"For example, using proteomics profiling, we have found that high systemic levels of S100A12 strongly correlated with the severity of COVID-19."	35105985	CustomKB
GNBR::J::Gene:Disease	long COVID	Disease	MONDO:0100233	TLR7	Gene	ENTREZ:51284	"Sex-related differences in the innate immune system may also be involved, including the fact that the gene encoding TLR7, which activates the IFN-I antiviral response, a key defense against SARS-CoV-2."	35912863	CustomKB
GNBR::J::Gene:Disease	RNase L enzyme	Gene	ENTREZ:6041	CFS	Disease	MONDO:0005404	"The 2-5A synthetase/RNase L pathway in CFS patients appears to be both up-regulated (i.e. increased levels of bioactive 2-5A synthetase and increased activity of the RNase L enzyme) and deregulated (elastase and calpain initiate 83 kDa RNase L proteolysis, generating two major fragments with molecular masses of 37 and 30 kDa, respectively)."	16277015	CustomKB
GNBR::J::Gene:Disease	83 kDa RNase L	Gene	ENTREZ:6041	CFS	Disease	MONDO:0005404	"The 2-5A synthetase/RNase L pathway in CFS patients appears to be both up-regulated (i.e. increased levels of bioactive 2-5A synthetase and increased activity of the RNase L enzyme) and deregulated (elastase and calpain initiate 83 kDa RNase L proteolysis, generating two major fragments with molecular masses of 37 and 30 kDa, respectively)."	16277015	CustomKB
GNBR::Md::Gene:Disease	alpha-1-macroglobulin	Gene	ENTREZ:2	CFS	Disease	MONDO:0005404	"The proteins were alpha-1-macroglobulin, amyloid precursor-like protein 1, keratin 16, orosomucoid 2 and pigment epithelium-derived factor."	16321154	CustomKB
GNBR::Md::Gene:Disease	amyloid precursor-like protein 1	Gene	ENTREZ:333	CFS	Disease	MONDO:0005404	"The proteins were alpha-1-macroglobulin, amyloid precursor-like protein 1, keratin 16, orosomucoid 2 and pigment epithelium-derived factor."	16321154	CustomKB
GNBR::Md::Gene:Disease	keratin 16	Gene	ENTREZ:3868	CFS	Disease	MONDO:0005404	"The proteins were alpha-1-macroglobulin, amyloid precursor-like protein 1, keratin 16, orosomucoid 2 and pigment epithelium-derived factor."	16321154	CustomKB
GNBR::Md::Gene:Disease	orosomucoid 2	Gene	ENTREZ:5005	CFS	Disease	MONDO:0005404	"The proteins were alpha-1-macroglobulin, amyloid precursor-like protein 1, keratin 16, orosomucoid 2 and pigment epithelium-derived factor."	16321154	CustomKB
GNBR::Md::Gene:Disease	pigment epithelium-derived factor	Gene	ENTREZ:5176	CFS	Disease	MONDO:0005404	"The proteins were alpha-1-macroglobulin, amyloid precursor-like protein 1, keratin 16, orosomucoid 2 and pigment epithelium-derived factor."	16321154	CustomKB
GNBR::Md::Gene:Disease	WASF3	Gene	ENTREZ:10810	CFS	Disease	MONDO:0005404	"In particular, the gene WASF3 (aka WAVE3) possibly regulates brain cytokines involved in the mechanism of fatigue through the p38 MAPK regulatory pathway."	21584188	CustomKB
GNBR::Md::Gene:Disease	IL-1α	Gene	ENTREZ:3552	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"These preliminary results suggest that IL-1α, 6 and 8 adjusted for illness duration may serve as robust biomarkers, independent of age, in screening for ME/CFS."	26965484	CustomKB
GNBR::Md::Gene:Disease	IL-6	Gene	ENTREZ:3569	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"These preliminary results suggest that IL-1α, 6 and 8 adjusted for illness duration may serve as robust biomarkers, independent of age, in screening for ME/CFS."	26965484	CustomKB
GNBR::Md::Gene:Disease	IL-8	Gene	ENTREZ:3576	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"These preliminary results suggest that IL-1α, 6 and 8 adjusted for illness duration may serve as robust biomarkers, independent of age, in screening for ME/CFS."	26965484	CustomKB
GNBR::Md::Gene:Disease	LPS-binding protein (LBP)	Gene	ENTREZ:3929	ME/CFS	Disease	MONDO:0005404	"We observed elevated levels of some blood markers for microbial translocation in ME/CFS patients; levels of LPS, LBP, and sCD14 were elevated in ME/CFS subjects."	27338587	CustomKB
GNBR::Md::Gene:Disease	soluble CD14 (sCD14)	Gene	ENTREZ:929	ME/CFS	Disease	MONDO:0005404	"We observed elevated levels of some blood markers for microbial translocation in ME/CFS patients; levels of LPS, LBP, and sCD14 were elevated in ME/CFS subjects."	27338587	CustomKB
GNBR::Md::Gene:Disease	activin B	Gene	ENTREZ:90	CFS/ME	Disease	MONDO:0005404	"Elevated activin B levels together with normal activin A levels identified patients with the diagnostic symptoms of CFS/ME, thus providing a novel serum based test."	28302133	CustomKB
GNBR::Md::Gene:Disease	TGF-β	Gene	ENTREZ:7040	ME/CFS	Disease	MONDO:0005404	"On average, TGF-β was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared with controls."	28760971	CustomKB
GNBR::Md::Gene:Disease	resistin	Gene	ENTREZ:56729	ME/CFS	Disease	MONDO:0005404	"On average, TGF-β was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared with controls."	28760971	CustomKB
GNBR::Md::Gene:Disease	CCL11 (Eotaxin-1)	Gene	ENTREZ:6356	ME/CFS	Disease	MONDO:0005404	"Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	CXCL1 (GROα)	Gene	ENTREZ:2919	ME/CFS	Disease	MONDO:0005404	"Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	CXCL10 (IP-10)	Gene	ENTREZ:3627	ME/CFS	Disease	MONDO:0005404	"Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	IFN-γ	Gene	ENTREZ:3458	ME/CFS	Disease	MONDO:0005404	"Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	IL-5	Gene	ENTREZ:3567	ME/CFS	Disease	MONDO:0005404	"Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	IL-4	Gene	ENTREZ:3565	ME/CFS	Disease	MONDO:0005404	"Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	IL-7	Gene	ENTREZ:3574	ME/CFS	Disease	MONDO:0005404	"Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	IL-12p70	Gene	ENTREZ:3593	ME/CFS	Disease	MONDO:0005404	"Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	IL-13	Gene	ENTREZ:3596	ME/CFS	Disease	MONDO:0005404	"Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	IL-17F	Gene	ENTREZ:112744	ME/CFS	Disease	MONDO:0005404	"Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	leptin	Gene	ENTREZ:3952	ME/CFS	Disease	MONDO:0005404	"Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	G-CSF	Gene	ENTREZ:1440	ME/CFS	Disease	MONDO:0005404	"Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	GM-CSF	Gene	ENTREZ:1437	ME/CFS	Disease	MONDO:0005404	"Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	LIF	Gene	ENTREZ:3976	ME/CFS	Disease	MONDO:0005404	"Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	NGF	Gene	ENTREZ:4803	ME/CFS	Disease	MONDO:0005404	"Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	SCF	Gene	ENTREZ:4254	ME/CFS	Disease	MONDO:0005404	"Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	TGF-α	Gene	ENTREZ:7039	ME/CFS	Disease	MONDO:0005404	"Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	CD40L	Gene	ENTREZ:959	Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME/CFS)	Disease	MONDO:0005404	"The most discriminatory cytokines post exercise were CD40L, platelet activator inhibitor, interleukin 1-β, interferon-α and CXCL1."	29426834	CustomKB
GNBR::Md::Gene:Disease	platelet activator inhibitor	Gene	ENTREZ:5196	Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME/CFS)	Disease	MONDO:0005404	"The most discriminatory cytokines post exercise were CD40L, platelet activator inhibitor, interleukin 1-β, interferon-α and CXCL1."	29426834	CustomKB
GNBR::Md::Gene:Disease	interleukin 1-β	Gene	ENTREZ:3553	Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME/CFS)	Disease	MONDO:0005404	"The most discriminatory cytokines post exercise were CD40L, platelet activator inhibitor, interleukin 1-β, interferon-α and CXCL1."	29426834	CustomKB
GNBR::Md::Gene:Disease	interferon-α	Gene	ENTREZ:111654	Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME/CFS)	Disease	MONDO:0005404	"The most discriminatory cytokines post exercise were CD40L, platelet activator inhibitor, interleukin 1-β, interferon-α and CXCL1."	29426834	CustomKB
GNBR::Md::Gene:Disease	CXCL1	Gene	ENTREZ:2919	Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME/CFS)	Disease	MONDO:0005404	"The most discriminatory cytokines post exercise were CD40L, platelet activator inhibitor, interleukin 1-β, interferon-α and CXCL1."	29426834	CustomKB
GNBR::Md::Gene:Disease	activin B	Gene	ENTREZ:3625	ME/CFS	Disease	MONDO:0005404	"On direct comparison of ME/CFS to study controls, only serum activin B was significantly elevated, with no significant variation observed for a broad range of serum and urine markers, or other serum cytokines."	29650052	CustomKB
GNBR::Md::Gene:Disease	phenylalanine	Gene	ENTREZ:5053	CFS	Disease	MONDO:0005404	"Interestingly, phenylalanine can be used as a potential biomarker for the diagnosis of CFS by SCRM."	30207334	CustomKB
GNBR::Md::Gene:Disease	creatine kinase (CK)	Gene	ENTREZ:5286	ME/CFS	Disease	MONDO:0005404	"Our results show that routine creatine kinase (CK) blood values, plasma EVs physical characteristics (including counts, size and zeta-potential), and a limited number of differentially expressed PBMC and EV miRNAs appear significantly associated with severe ME/CFS (p < 0.05)."	32034172	CustomKB
GNBR::Md::Gene:Disease	corticotropin-releasing factor receptor type 2 (CRFR2)	Gene	ENTREZ:1395	Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"The trial supports the hypothesis that CRFR2 is upregulated in ME/CFS, and that acute CRFR2 agonism may be a viable treatment approach warranting further study."	34539356	CustomKB
GNBR::Md::Gene:Disease	non-coding RNA (ncRNA)	Gene	ENTREZ:552853	CFS	Disease	MONDO:0005404	"In this review, we discuss the infectious, genetic, and hormonal components that may be involved in CFS pathogenesis, we scrutinize the role of gut microbiota in disease progression, we highlight the potential of non-coding RNA (ncRNA) for the development of diagnostic tools and briefly mention the possibility of SARS-CoV-2 infection causing CFS."	34682909	CustomKB
GNBR::Md::Gene:Disease	nitric oxide synthase (eNOS)	Gene	ENTREZ:4846	Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"In conclusion, this study in vitro shows a decreased NO production in HUVECs exposed to plasma from ME/CFS patients, suggesting an unreported role of eNOS in the pathophysiology of this disease."	35074481	CustomKB
GNBR::Md::Gene:Disease	transient receptor potential melastatin 3 (TRPM3)	Gene	ENTREZ:80036	ME/CFS	Disease	MONDO:0005404	"Collectively, these findings validate that TRPM3 loss of function results in altered Ca2+ influx supporting the growing evidence that ME/CFS is a TRP ion channel disorder and that NTX provides a potential therapeutic intervention for ME/CFS."	35172836	CustomKB
GNBR::Md::Gene:Disease	Endothelin-1 (ET-1)	Gene	ENTREZ:1906	Post-COVID Syndrome (PCS)	Disease	MONDO:0100233	The ET-1 concentration was significantly elevated in both ME/CFS and PCS patients compared to HCs and PCHCs.	35317812	CustomKB
GNBR::Md::Gene:Disease	Endothelin-1 (ET-1)	Gene	ENTREZ:1906	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)	Disease	MONDO:0005404	The ET-1 concentration was significantly elevated in both ME/CFS and PCS patients compared to HCs and PCHCs.	35317812	CustomKB
GNBR::Md::Gene:Disease	IL-13	Gene	ENTREZ:3596	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"From analyses using receiver operating characteristic statistics, the students who had had severe gastrointestinal symptoms of stomach pain, bloating, and an irritable bowel at baseline and who also had abnormally low levels of the immune markers IL-13 and/or IL-5 at baseline, as well as severe gastrointestinal symptoms when then contracted IM, were found to have a nearly 80% chance of having severe ME/CFS persisting six months following IM."	35350440	CustomKB
GNBR::Md::Gene:Disease	IL-5	Gene	ENTREZ:3567	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"From analyses using receiver operating characteristic statistics, the students who had had severe gastrointestinal symptoms of stomach pain, bloating, and an irritable bowel at baseline and who also had abnormally low levels of the immune markers IL-13 and/or IL-5 at baseline, as well as severe gastrointestinal symptoms when then contracted IM, were found to have a nearly 80% chance of having severe ME/CFS persisting six months following IM."	35350440	CustomKB
GNBR::Md::Gene:Disease	TGFB	Gene	ENTREZ:7040	ME/CFS	Disease	MONDO:0005404	"We propose that disrupted TGFB signaling in ME/CFS may play a role in disrupting physiological rhythms in sleep, activity, and cognition, leading to the insomnia, energy disturbances, cognition problems, depression, and autonomic dysfunction associated with ME/CFS."	35465246	CustomKB
GNBR::Md::Gene:Disease	fibronectin (FN1)	Gene	ENTREZ:2335	Myalgic Encephalomyelitis/ Chronic Fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	Finding of increased circulating FN1 and depletion of (n)IgM-FN1 as a biomarker for the severity of both ME/CFS and long COVID has an immediate implication in diagnostics and development of treatment modalities.	37425897	CustomKB
GNBR::Md::Gene:Disease	fibronectin (FN1)	Gene	ENTREZ:14268	long COVID	Disease	MONDO:0100233	Finding of increased circulating FN1 and depletion of (n)IgM-FN1 as a biomarker for the severity of both ME/CFS and long COVID has an immediate implication in diagnostics and development of treatment modalities.	37425897	CustomKB
GNBR::Md::Gene:Disease	IgM against fibronectin ((n)IgM-FN1)	Gene	ENTREZ:959	Myalgic Encephalomyelitis/ Chronic Fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	Finding of increased circulating FN1 and depletion of (n)IgM-FN1 as a biomarker for the severity of both ME/CFS and long COVID has an immediate implication in diagnostics and development of treatment modalities.	37425897	CustomKB
GNBR::Md::Gene:Disease	IgM against fibronectin ((n)IgM-FN1)	Gene	ENTREZ:959	long COVID	Disease	MONDO:0100233	Finding of increased circulating FN1 and depletion of (n)IgM-FN1 as a biomarker for the severity of both ME/CFS and long COVID has an immediate implication in diagnostics and development of treatment modalities.	37425897	CustomKB
GNBR::Md::Gene:Disease	ATG13	Gene	ENTREZ:9776	ME/CFS	Disease	MONDO:0005404	"Collectively, our results suggest that an impairment of autophagy following the release of ATG13 into serum could be a pathological signal in ME/CFS."	35487443	CustomKB
GNBR::Md::Gene:Disease	TNF-α	Gene	ENTREZ:7124	post-COVID-19	Disease	MONDO:0100233	TNF-α could be a promising biomarker for predicting pulmonary complications and may be a potential target for therapeutic intervention in patients with post-COVID-19 complications.	37445288	CustomKB
GNBR::Md::Gene:Disease	anti-M4 AchR	Gene	ENTREZ:1132	ME/CFS	Disease	MONDO:0005404	Elevated levels of antibodies against β2AdR and M4 receptors in ME/CFS patients support their usage as clinical biomarkers in the diagnostic algorithm of ME/CFS.	36300129	CustomKB
GNBR::Md::Gene:Disease	anti-β2AdR	Gene	ENTREZ:154	ME/CFS	Disease	MONDO:0005404	Elevated levels of antibodies against β2AdR and M4 receptors in ME/CFS patients support their usage as clinical biomarkers in the diagnostic algorithm of ME/CFS.	36300129	CustomKB
GNBR::Md::Gene:Disease	Interleukin 6	Gene	ENTREZ:3570	long COVID	Disease	MONDO:0100233	"Of these, up-regulated Interleukin 6, C-reactive protein, and tumor necrosis factor alpha might serve as the potential diagnostic biomarkers for long COVID."	36744129	CustomKB
GNBR::Md::Gene:Disease	C-reactive protein	Gene	ENTREZ:1401	long COVID	Disease	MONDO:0100233	"Of these, up-regulated Interleukin 6, C-reactive protein, and tumor necrosis factor alpha might serve as the potential diagnostic biomarkers for long COVID."	36744129	CustomKB
GNBR::Md::Gene:Disease	tumor necrosis factor alpha	Gene	ENTREZ:7124	long COVID	Disease	MONDO:0100233	"Of these, up-regulated Interleukin 6, C-reactive protein, and tumor necrosis factor alpha might serve as the potential diagnostic biomarkers for long COVID."	36744129	CustomKB
GNBR::Md::Gene:Disease	P-SEL	Gene	ENTREZ:6403	Long-COVID	Disease	MONDO:0100233	"Vascular transformation blood biomarkers were significantly elevated in Long-COVID, with angiogenesis markers (ANG-1/P-SEL) providing classification accuracy of 96%."	36217108	CustomKB
GNBR::Md::Gene:Disease	ANG-1	Gene	ENTREZ:284	Long-COVID	Disease	MONDO:0100233	"Vascular transformation blood biomarkers were significantly elevated in Long-COVID, with angiogenesis markers (ANG-1/P-SEL) providing classification accuracy of 96%."	36217108	CustomKB
GNBR::Md::Gene:Disease	long COVID	Disease	MONDO:0100233	B2M	Gene	ENTREZ:567	"The gene ontology analysis of common genes (CXCL8, B2M, SOD1, BCL2, EGF, SERPINE1, S100A8, S100A9, and HMGB1)."	36189286	CustomKB
GNBR::Md::Gene:Disease	long COVID	Disease	MONDO:0100233	SOD1	Gene	ENTREZ:6647	"The gene ontology analysis of common genes (CXCL8, B2M, SOD1, BCL2, EGF, SERPINE1, S100A8, S100A9, and HMGB1)."	36189286	CustomKB
GNBR::Md::Gene:Disease	long COVID	Disease	MONDO:0100233	BCL2	Gene	ENTREZ:596	"The gene ontology analysis of common genes (CXCL8, B2M, SOD1, BCL2, EGF, SERPINE1, S100A8, S100A9, and HMGB1)."	36189286	CustomKB
GNBR::Md::Gene:Disease	long COVID	Disease	MONDO:0100233	EGF	Gene	ENTREZ:1950	" The gene ontology analysis of common genes (CXCL8, B2M, SOD1, BCL2, EGF, SERPINE1, S100A8, S100A9, and HMGB1)."	36189286	CustomKB
GNBR::Md::Gene:Disease	long COVID	Disease	MONDO:0100233	SERPINE1	Gene	ENTREZ:5054	" The gene ontology analysis of common genes (CXCL8, B2M, SOD1, BCL2, EGF, SERPINE1, S100A8, S100A9, and HMGB1)."	36189286	CustomKB
GNBR::Md::Gene:Disease	long COVID	Disease	MONDO:0100233	S100A8	Gene	ENTREZ:6279	"The gene ontology analysis of common genes (CXCL8, B2M, SOD1, BCL2, EGF, SERPINE1, S100A8, S100A9, and HMGB1)."	36189286	CustomKB
GNBR::Md::Gene:Disease	long COVID	Disease	MONDO:0100233	S100A9	Gene	ENTREZ:6280	"The gene ontology analysis of common genes (CXCL8, B2M, SOD1, BCL2, EGF, SERPINE1, S100A8, S100A9, and HMGB1)."	36189286	CustomKB
GNBR::Md::Gene:Disease	long COVID	Disease	MONDO:0100233	HMGB1	Gene	ENTREZ:3146	" The gene ontology analysis of common genes (CXCL8, B2M, SOD1, BCL2, EGF, SERPINE1, S100A8, S100A9, and HMGB1)."	36189286	CustomKB
GNBR::Md::Gene:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	CXCL8	Gene	ENTREZ:3576	"The gene ontology analysis of common genes (CXCL8, B2M, SOD1, BCL2, EGF, SERPINE1, S100A8, S100A9, and HMGB1)."	36189286	CustomKB
GNBR::Md::Gene:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	B2M	Gene	ENTREZ:567	"The gene ontology analysis of common genes (CXCL8, B2M, SOD1, BCL2, EGF, SERPINE1, S100A8, S100A9, and HMGB1)."	36189286	CustomKB
GNBR::Md::Gene:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	SOD1	Gene	ENTREZ:6647	"The gene ontology analysis of common genes (CXCL8, B2M, SOD1, BCL2, EGF, SERPINE1, S100A8, S100A9, and HMGB1)."	36189286	CustomKB
GNBR::Md::Gene:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	BCL2	Gene	ENTREZ:596	"The gene ontology analysis of common genes (CXCL8, B2M, SOD1, BCL2, EGF, SERPINE1, S100A8, S100A9, and HMGB1)."	36189286	CustomKB
GNBR::Md::Gene:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	EGF	Gene	ENTREZ:1950	"The gene ontology analysis of common genes (CXCL8, B2M, SOD1, BCL2, EGF, SERPINE1, S100A8, S100A9, and HMGB1)."	36189286	CustomKB
GNBR::Md::Gene:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	SERPINE1	Gene	ENTREZ:5054	"The gene ontology analysis of common genes (CXCL8, B2M, SOD1, BCL2, EGF, SERPINE1, S100A8, S100A9, and HMGB1)."	36189286	CustomKB
GNBR::Md::Gene:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	S100A8	Gene	ENTREZ:6279	" The gene ontology analysis of common genes (CXCL8, B2M, SOD1, BCL2, EGF, SERPINE1, S100A8, S100A9, and HMGB1)."	36189286	CustomKB
GNBR::Md::Gene:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	S100A9	Gene	ENTREZ:6280	"The gene ontology analysis of common genes (CXCL8, B2M, SOD1, BCL2, EGF, SERPINE1, S100A8, S100A9, and HMGB1)."	36189286	CustomKB
GNBR::Md::Gene:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	HMGB1	Gene	ENTREZ:3146	" The gene ontology analysis of common genes (CXCL8, B2M, SOD1, BCL2, EGF, SERPINE1, S100A8, S100A9, and HMGB1)."	36189286	CustomKB
GNBR::Md::Gene:Disease	long COVID	Disease	MONDO:0100233	CD8A	Gene	ENTREZ:925	"According to the degree in the PPI network, the top 5 hub proteins as IL-6, IL-1B, CD8A, TP53, and CXCL8 were listed through the cytoHubba plugin."	36189286	CustomKB
GNBR::Md::Gene:Disease	long COVID	Disease	MONDO:0100233	TP53	Gene	ENTREZ:7157	" According to the degree in the PPI network, the top 5 hub proteins as IL-6, IL-1B, CD8A, TP53, and CXCL8 were listed through the cytoHubba plugin."	36189286	CustomKB
GNBR::Md::Gene:Disease	long COVID	Disease	MONDO:0100233	CXCL8	Gene	ENTREZ:3576	"The gene ontology analysis of common genes (CXCL8, B2M, SOD1, BCL2, EGF, SERPINE1, S100A8, S100A9, and HMGB1)."	36189286	CustomKB
GNBR::Md::Gene:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	CD8A	Gene	ENTREZ:925	" According to the degree in the PPI network, the top 5 hub proteins as IL-6, IL-1B, CD8A, TP53, and CXCL8 were listed through the cytoHubba plugin."	36189286	CustomKB
GNBR::Md::Gene:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	TP53	Gene	ENTREZ:7157	"According to the degree in the PPI network, the top 5 hub proteins as IL-6, IL-1B, CD8A, TP53, and CXCL8 were listed through the cytoHubba plugin."	36189286	CustomKB
GNBR::Md::Gene:Disease	neuropeptide Y	Gene	ENTREZ:4852	Chronic fatigue syndrome	Disease	MONDO:0005404	"The significant correlations of NPY with stress, negative mood, general health, depression and cognitive function strongly suggest that this peptide be considered as a biomarker to distinguish subsets of CFS."	21190576	CustomKB
GNBR::Md::Gene:Disease	IgM	Gene	ENTREZ:959	long COVID	Disease	MONDO:0100233	"We discover an immunoglobulin (Ig) signature, based on total IgM and IgG3 levels, which - combined with age, history of asthma bronchiale, and five symptoms during primary infection - is able to predict the risk of PACS independently of timepoint of blood sampling."	35078982	CustomKB
GNBR::Md::Gene:Disease	IgG3	Gene	ENTREZ:3502	long COVID	Disease	MONDO:0100233	"We discover an immunoglobulin (Ig) signature, based on total IgM and IgG3 levels, which - combined with age, history of asthma bronchiale, and five symptoms during primary infection - is able to predict the risk of PACS independently of timepoint of blood sampling."	35078982	CustomKB
GNBR::Md::Gene:Disease	activin B	Gene	ENTREZ:11479	chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)	Disease	MONDO:0005404	"Serum activin B levels for CFS/ME participants were significantly elevated when compared to the study controls, as well as the established reference interval. Serum activin A and follistatin were within their normal ranges."	28302133	CustomKB
GNBR::Md::Gene:Disease	TGF-β	Gene	ENTREZ:7040	myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"On average, TGF-β was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared with controls. Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	resistin	Gene	ENTREZ:56729	myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"On average, TGF-β was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared with controls. Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	CCL11 (Eotaxin-1)	Gene	ENTREZ:6356	myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"On average, TGF-β was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared with controls. Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	CXCL1 (GROα)	Gene	ENTREZ:2919	myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"On average, TGF-β was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared with controls. Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	CXCL10 (IP-10)	Gene	ENTREZ:3627	myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"On average, TGF-β was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared with controls. Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	IFN-γ	Gene	ENTREZ:3458	myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"On average, TGF-β was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared with controls. Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	IL-4	Gene	ENTREZ:3565	myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"On average, TGF-β was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared with controls. Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	IL-5	Gene	ENTREZ:3567	myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"On average, TGF-β was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared with controls. Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	IL-7	Gene	ENTREZ:3574	myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"On average, TGF-β was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared with controls. Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	IL-12p70	Gene	ENTREZ:3593	myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"On average, TGF-β was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared with controls. Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	IL-13	Gene	ENTREZ:3596	myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"On average, TGF-β was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared with controls. Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	IL-17F	Gene	ENTREZ:112744	myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"On average, TGF-β was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared with controls. Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	leptin	Gene	ENTREZ:3952	myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"On average, TGF-β was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared with controls. Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	G-CSF	Gene	ENTREZ:1440	myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"On average, TGF-β was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared with controls. Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	GM-CSF	Gene	ENTREZ:1437	myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"On average, TGF-β was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared with controls. Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	LIF	Gene	ENTREZ:3976	myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"On average, TGF-β was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared with controls. Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	NGF	Gene	ENTREZ:4803	myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"On average, TGF-β was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared with controls. Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	SCF	Gene	ENTREZ:652070	myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"On average, TGF-β was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared with controls. Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	TGF-α	Gene	ENTREZ:7039	myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"On average, TGF-β was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared with controls. Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity: CCL11 (Eotaxin-1), CXCL1 (GROα), CXCL10 (IP-10), IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF-α."	28760971	CustomKB
GNBR::Md::Gene:Disease	CXCL9 (MIG)	Gene	ENTREZ:4283	myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	Only CXCL9 (MIG) inversely correlated with fatigue duration.	28760971	CustomKB
GNBR::Md::Gene:Disease	CD40L	Gene	ENTREZ:959	Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME/CFS)	Disease	MONDO:0005404	"The most discriminatory cytokines post exercise were CD40L, platelet activator inhibitor, interleukin 1-β, interferon-α and CXCL1. In conclusion, cytokine profiling following exercise may help differentiate patients with ME/CFS from sedentary controls."	29426834	CustomKB
GNBR::Md::Gene:Disease	platelet activator inhibitor	Gene	ENTREZ:5054	Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME/CFS)	Disease	MONDO:0005404	"The most discriminatory cytokines post exercise were CD40L, platelet activator inhibitor, interleukin 1-β, interferon-α and CXCL1. In conclusion, cytokine profiling following exercise may help differentiate patients with ME/CFS from sedentary controls."	29426834	CustomKB
GNBR::Md::Gene:Disease	interleukin 1-β	Gene	ENTREZ:3553	Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME/CFS)	Disease	MONDO:0005404	"The most discriminatory cytokines post exercise were CD40L, platelet activator inhibitor, interleukin 1-β, interferon-α and CXCL1. In conclusion, cytokine profiling following exercise may help differentiate patients with ME/CFS from sedentary controls."	29426834	CustomKB
GNBR::Md::Gene:Disease	interferon-α	Gene	ENTREZ:3454	Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME/CFS)	Disease	MONDO:0005404	"The most discriminatory cytokines post exercise were CD40L, platelet activator inhibitor, interleukin 1-β, interferon-α and CXCL1. In conclusion, cytokine profiling following exercise may help differentiate patients with ME/CFS from sedentary controls."	29426834	CustomKB
GNBR::Md::Gene:Disease	CXCL1	Gene	ENTREZ:2919	Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME/CFS)	Disease	MONDO:0005404	"The most discriminatory cytokines post exercise were CD40L, platelet activator inhibitor, interleukin 1-β, interferon-α and CXCL1. In conclusion, cytokine profiling following exercise may help differentiate patients with ME/CFS from sedentary controls."	29426834	CustomKB
GNBR::Mp::Compound:Disease	lipopolysaccharide (LPS)	Compound	MESH:D004731	ME/CFS	Disease	MONDO:0005404	"We observed elevated levels of some blood markers for microbial translocation in ME/CFS patients; levels of LPS, LBP, and sCD14 were elevated in ME/CFS subjects."	27338587	CustomKB
GNBR::Mp::Compound:Disease	thyroid hormone	Compound	DrugBank:DB00451	Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"a ""vicious circle"" between inflammation, oxidative and nitrosative stress (O&NS), and low thyroid hormone function"	33585528	CustomKB
GNBR::Mp::Compound:Disease	nitric oxide (NO)	Compound	DrugBank:DB00435	Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"In conclusion, this study in vitro shows a decreased NO production in HUVECs exposed to plasma from ME/CFS patients, suggesting an unreported role of eNOS in the pathophysiology of this disease."	35074481	CustomKB
GNBR::Mp::Compound:Disease	Angiopoietin-2 (Ang-2)	Compound	MESH:D042702	Post-COVID Syndrome (PCS)	Disease	MONDO:0100233	The serum Ang-2 concentration was lower in both PCS patients and PCHCs compared to HCs.	35317812	CustomKB
GNBR::Mp::Compound:Disease	cortisol	Compound	DrugBank:DB00741	ME/CFS	Disease	MONDO:0005404	"While there were significant differences found in urinary free cortisol levels in ME/CFS patients, there was also substantial heterogeneity across the included studies that makes drawing conclusions difficult."	37408028	CustomKB
GNBR::Mp::Compound:Disease	plasmalogens	Compound	MESH:D010955	ME/CFS	Disease	MONDO:0005404	"Subjects in the ME/CFS group had significantly decreased levels of plasmalogens and phospholipid ethers (p < 0.001), phosphatidylcholines (p < 0.001) and sphingomyelins (p < 0.001), and elevated levels of dicarboxylic acids (p = 0.013)."	35887252	CustomKB
GNBR::Mp::Compound:Disease	phospholipid ethers	Compound	MESH:D010742	ME/CFS	Disease	MONDO:0005404	"Subjects in the ME/CFS group had significantly decreased levels of plasmalogens and phospholipid ethers (p < 0.001), phosphatidylcholines (p < 0.001) and sphingomyelins (p < 0.001), and elevated levels of dicarboxylic acids (p = 0.013)."	35887252	CustomKB
GNBR::Mp::Compound:Disease	phosphatidylcholines	Compound	MESH:D010713	ME/CFS	Disease	MONDO:0005404	"Subjects in the ME/CFS group had significantly decreased levels of plasmalogens and phospholipid ethers (p < 0.001), phosphatidylcholines (p < 0.001) and sphingomyelins (p < 0.001), and elevated levels of dicarboxylic acids (p = 0.013)."	35887252	CustomKB
GNBR::Mp::Compound:Disease	sphingomyelins	Compound	MESH:D013109	ME/CFS	Disease	MONDO:0005404	"Subjects in the ME/CFS group had significantly decreased levels of plasmalogens and phospholipid ethers (p < 0.001), phosphatidylcholines (p < 0.001) and sphingomyelins (p < 0.001), and elevated levels of dicarboxylic acids (p = 0.013)."	35887252	CustomKB
GNBR::Mp::Compound:Disease	dicarboxylic acids	Compound	MESH:D003998	ME/CFS	Disease	MONDO:0005404	"Subjects in the ME/CFS group had significantly decreased levels of plasmalogens and phospholipid ethers (p < 0.001), phosphatidylcholines (p < 0.001) and sphingomyelins (p < 0.001), and elevated levels of dicarboxylic acids (p = 0.013)."	35887252	CustomKB
GNBR::Mp::Compound:Disease	neurofilament light chain	Gene	ENTREZ:4747	long COVID	Disease	MONDO:0100233	"Of these, up-regulated Interleukin 6, C-reactive protein, and tumor necrosis factor alpha might serve as the potential diagnostic biomarkers for long COVID."	36744129	CustomKB
GNBR::Mp::Compound:Disease	cortisol	Compound	DrugBank:DB00741	Long COVID	Disease	MONDO:0100233	"Integration of immune phenotyping data into unbiased machine learning models identified significant distinguishing features critical in accurate classification of Long COVID, with decreased levels of cortisol being the most significant individual predictor."	35982667	CustomKB
GNBR::Mp::Compound:Disease	long COVID	Disease	MONDO:0100233	Homocysteine	Compound	DrugBank:DB04422	Long COVID may be associated with an elevation of the biomarker homocysteine(Hcy) with resulting hyperhomocysteinemia (HHcy).	35056324	CustomKB
GNBR::Pa::Compound:Disease	long COVID	Disease	MONDO:0100233	Melatonin	Compound	DrugBank:DB01065	"Melatonin may be particularly effective at reducing the signs and symptoms of SARS-CoV-2 infection due to its functions as an antioxidant, anti-inflammatory, and immuno-modulatory agent."	36358996	CustomKB
GNBR::Pa::Compound:Disease	long COVID	Disease	MONDO:0100233	Luteolin	Compound	DrugBank:DB15584	These processes could be mitigated by phytosomal formulation (in olive pomace oil) of the natural flavonoid luteolin.	33847020	CustomKB
GNBR::Pa::Compound:Disease	COVID-19	Disease	MONDO:0100096	Remdesivir	Compound	DrugBank:DB14761	"From an analysis of 27 publications that were surveyed on the ability of drugs to successfully treat COVTD-19,it was concluded that melatonin is at least twice as effective as remdesivir or tocilizumab in reducing the inflammatory markers of a coronavirus 2019 infection."	36358996	CustomKB
GNBR::Pa::Compound:Disease	COVID-19	Disease	MONDO:0100096	Tocilizumab	Compound	DrugBank:DB06273	"From an analysis of 27 publications that were surveyed on the ability of drugs to successfully treat COVTD-19,it was concluded that melatonin is at least twice as effective as remdesivir or tocilizumab in reducing the inflammatory markers of a coronavirus 2019 infection."	36358996	CustomKB
GNBR::Pa::Compound:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	Oxaloacetate Ion	Compound	DrugBank:DB02637	"Potential clinical applications with anhydrous enol-oxaloacetate, currently a commercial nutritional supplement, may help reduce fatigue in ME/CFS and Long-COVID patients."	35764955	CustomKB
GNBR::Pa::Compound:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	Tocilizumab	Compound	DrugBank:DB06273	34588793	34588793	CustomKB
GNBR::Pa::Compound:Disease	long COVID	Disease	MONDO:0100233	Remdesivir	Compound	DrugBank:DB14761	"Remdesivir had a very large effect at regulating levels of C-reactive protein, moderate effects at increasing lymphocyte levels, and a negligible dysregulating effect on ferritin levels."	34588793	CustomKB
GNBR::Pa::Compound:Disease	long COVID	Disease	MONDO:0100233	"24-Homo-1,25-dihydroxyvitamin D3"	Compound	DrugBank:DB15557	"Vitamin D3 demonstrated very large reductions in TNF-a and IL-6 trans levels, moderate effects on increasing IL-6 classic levels, and small dysregulation of IL-10."	34588793	CustomKB
GNBR::Pa::Compound:Disease	long COVID	Disease	MONDO:0100233	Tocilizumab	Compound	DrugBank:DB06273	Tocilizumab showed a very small dysregulating effect on C-reactive protein and a negligible dysregulating effect on erythrocyte sedimentation rates.	34588793	CustomKB
GNBR::Pa::Compound:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	Curcumin	Compound	DrugBank:DB11672	"Curcumin has shown benefits in a variety of diseases involving oxidative stress, including ME/CFS, rheumatoid arthritis, and acute COVID-19."	36043493	CustomKB
GNBR::Pa::Compound:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	Flavonoids	Compound	DrugBank:DB14586	"Flavonoids have shown benefits in rheumatoid arthritis, in ME/CFS, and even activity against coronaviruses such as the SARS-CoV-2 responsible for acute COVID-19 and Long COVID."	36043493	CustomKB
GNBR::Pa::Compound:Disease	long COVID	Disease	MONDO:0100233	Flavonoids	Compound	DrugBank:DB14586	"Flavonoids have shown benefits in rheumatoid arthritis, in ME/CFS, and even activity against coronaviruses such as the SARS-CoV-2 responsible for acute COVID-19 and Long COVID."	36043493	CustomKB
GNBR::Pa::Compound:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	Magnesium	Compound	DrugBank:DB14513	"Intriguingly, populations exhibiting low magnesium ion levels were found to be more susceptible to COVID-19, and magnesium supplementation has shown benefits in SARS-CoV-2 therapy, ME/CFS, and in maintaining endothelial cell function."	36043493	CustomKB
GNBR::Pa::Compound:Disease	long COVID	Disease	MONDO:0100233	Magnesium	Compound	DrugBank:DB14513	"Intriguingly, populations exhibiting low magnesium ion levels were found to be more susceptible to COVID-19, and magnesium supplementation has shown benefits in SARS-CoV-2 therapy, ME/CFS, and in maintaining endothelial cell function."	36043493	CustomKB
GNBR::Pa::Compound:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	Folic acid	Compound	DrugBank:DB00158	Patients with ME/CFS respond positively to oral folic acid.	35056324	CustomKB
GNBR::Pa::Compound:Disease	long COVID	Disease	MONDO:0100233	Folic acid	Compound	DrugBank:DB00158	Patients with Long COVID respond positively to oral folic acid.	35056324	CustomKB
GNBR::Pa::Compound:Disease	long COVID	Disease	MONDO:0100233	Prednisone	Compound	DrugBank:DB00635	Small doses of prednisone block inflammation in Long COVID.	35056324	CustomKB
GNBR::Pa::Compound:Disease	Chest Pain	Disease	MESH:D002637	Sulodexide	Compound	DrugBank:DB06271	Sulodexide significantly improves long-lasting post-COVID-19 endothelial dysfunction and alleviates chest pain and palpitations.	35647070	CustomKB
GNBR::Pr::Compound:Disease	growth hormone (GH)	Compound	MESH:D013006	COVID-19	Disease	MONDO:0100233	Certain prolonged symptoms of COVID-19 might be accounted for by such hormonal disturbance.	35831125	CustomKB
GNBR::Pr::Compound:Disease	adrenocorticotropic hormone (ACTH)	Compound	MESH:C006418	COVID-19	Disease	MONDO:0100233	Certain prolonged symptoms of COVID-19 might be accounted for by such hormonal disturbance.	35831125	CustomKB
GNBR::Pr::Compound:Disease	long COVID	Disease	MONDO:0100233	Recombinant Human Angiotensin-Converting Enzyme 2	Compound	DrugBank:DB15736	Protective factors for long COVID in children include reduced angiotensin-converting enzyme 2(ACE2) receptor expression.	35739136	CustomKB
GNBR::Pr::Compound:Disease	long COVID	Disease	MONDO:0100233	Resveratrol	Compound	DrugBank:DB02709	"Natural substances contained in fruit and vegetables, such as resveratrol has the effect of  limiting the cytokine storm that occurs in patients with persistent inflammation and autoimmunity that may occur in long COVID-19."	35454144	CustomKB
GNBR::Pr::Compound:Disease	long COVID	Disease	MONDO:0100233	Quercetin	Compound	DrugBank:DB04216	"Natural substances contained in fruit and vegetables, such as quercetin has the effect of limiting the cytokine storm that occurs in patients with persistent inflammation and autoimmunity that may occur in long COVID-19."	35454144	CustomKB
GNBR::Pr::Compound:Disease	long COVID	Disease	MONDO:0100233	Sulforaphane	Compound	DrugBank:DB12422	" Natural substances contained in fruit and vegetables, such as sulforaphane has the effect of limiting the cytokine storm that occurs in patients with persistent inflammation and autoimmunity that may occur in long COVID-19."	35454144	CustomKB
GNBR::Pr::Compound:Disease	long COVID	Disease	MONDO:0100233	Curcumin	Compound	DrugBank:DB11672	" Natural substances contained in fruit and vegetables, such as curcumin has the effect of limiting the cytokine storm that occurs in patients with persistent inflammation and autoimmunity that may occur in long COVID-19."	35454144	CustomKB
GNBR::Pr::Compound:Disease	thrombosis	Disease	MONDO:0000831	Heparin	Compound	DrugBank:DB01109	Heparin can inhibit thrombus re-formation by inactivating clotting factors.	35449732	CustomKB
GNBR::Pr::Compound:Disease	long COVID	Disease	MONDO:0100233	Modafinil	Compound	DrugBank:DB00745	Modafinil can be a safe and effective intervention in combating fatigue associated with the Long COVID.	35761861	CustomKB
GNBR::T::Compound:Disease	rituximab	Compound	DrugBank:DB00073	ME/CFS	Disease	MONDO:0005404	"Consistently, clinical trials from Norway have shown that B-cell depletion with rituximab results in clinical benefits in about half of ME/CFS patients."	29635081	CustomKB
GNBR::T::Compound:Disease	melatonin	Compound	DrugBank:DB01065	ME/CFS	Disease	MONDO:0005404	"In this paper, these pathways are summarised, and data regarding promising therapeutic options that target these pathways are highlighted; they include coenzyme Q10, melatonin, curcumin, molecular hydrogen and N-acetylcysteine."	31509764	CustomKB
GNBR::T::Compound:Disease	curcumin	Compound	DrugBank:DB11672	ME/CFS	Disease	MONDO:0005404	"In this paper, these pathways are summarised, and data regarding promising therapeutic options that target these pathways are highlighted; they include coenzyme Q10, melatonin, curcumin, molecular hydrogen and N-acetylcysteine."	31509764	CustomKB
GNBR::T::Compound:Disease	molecular hydrogen	Compound	DrugBank:DB15127	ME/CFS	Disease	MONDO:0005404	"In this paper, these pathways are summarised, and data regarding promising therapeutic options that target these pathways are highlighted; they include coenzyme Q10, melatonin, curcumin, molecular hydrogen and N-acetylcysteine."	31509764	CustomKB
GNBR::T::Compound:Disease	N-acetylcysteine	Compound	MESH:C098444	ME/CFS	Disease	MONDO:0005404	"In this paper, these pathways are summarised, and data regarding promising therapeutic options that target these pathways are highlighted; they include coenzyme Q10, melatonin, curcumin, molecular hydrogen and N-acetylcysteine."	31509764	CustomKB
GNBR::T::Compound:Disease	favipiravir	Compound	DrugBank:DB12466	COVID-19	Disease	MONDO:0100096	"The initial clinical studies revealed the promising therapeutic potential of several of such drugs, including favipiravir, a broad-spectrum antiviral drug that interferes with the viral replication, and hydroxychloroquine, the repurposed antimalarial drug that interferes with the virus endosomal entry pathway."	32290293	CustomKB
GNBR::T::Compound:Disease	hydroxychloroquine	Compound	DrugBank:DB01611	COVID-19	Disease	MONDO:0100096	"The initial clinical studies revealed the promising therapeutic potential of several of such drugs, including favipiravir, a broad-spectrum antiviral drug that interferes with the viral replication, and hydroxychloroquine, the repurposed antimalarial drug that interferes with the virus endosomal entry pathway."	32290293	CustomKB
GNBR::T::Compound:Disease	oxygen-ozone autohemotherapy (O2-O3-AHT)	Compound	DrugBank:DB09140	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)	Disease	MONDO:0005404	"Treatment with O2-O3-AHT greatly improves ME/CFS related fatigue, aside from sex and age distribution."	35011770	CustomKB
GNBR::T::Compound:Disease	Naltrexone hydrochloride (NTX)	Compound	DrugBank:DB00704	Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"Collectively, these findings validate that TRPM3 loss of function results in altered Ca2+ influx supporting the growing evidence that ME/CFS is a TRP ion channel disorder and that NTX provides a potential therapeutic intervention for ME/CFS."	35172836	CustomKB
GNBR::T::Compound:Disease	Pyridostigmine	Compound	DrugBank:DB00545	ME/CFS	Disease	MONDO:0005404	Pyridostigmine improves peak Vo2 in ME/CFS by increasing cardiac output and right ventricular filling pressures.	35526605	CustomKB
GNBR::T::Compound:Disease	fluvoxamine	Compound	DrugBank:DB00176	long COVID	Disease	MONDO:0100233	"In addition, the author discusses potential therapeutic approaches based on the gut-brain axis, including plant-based diet, probiotics and prebiotics, fecal microbiota transplantation, and vagus nerve stimulation, and sigma-1 receptor agonist fluvoxamine."	37402856	CustomKB
GNBR::T::Compound:Disease	anhydrous enol oxaloacetate	Compound	DrugBank:DB02637	ME/CFS	Disease	MONDO:0005404	"As there has been little progress in providing fatigue relief for the millions of ME/CFS and Long COVID patients, anhydrous enol oxaloacetate may bridge this important medical need."	35764955	CustomKB
GNBR::T::Compound:Disease	anhydrous enol oxaloacetate	Compound	DrugBank:DB02637	Long COVID	Disease	MONDO:0100233	"As there has been little progress in providing fatigue relief for the millions of ME/CFS and Long COVID patients, anhydrous enol oxaloacetate may bridge this important medical need."	35764955	CustomKB
GNBR::T::Compound:Disease	melatonin	Compound	DrugBank:DB01065	ME/CFS	Disease	MONDO:0005404	This narrative review discusses the application of melatonin as a neuroprotective agent to control cognitive deterioration ("brain fog") and pain in the ME/CFS syndrome-like documented in long COVID.	36358996	CustomKB
GNBR::T::Compound:Disease	melatonin	Compound	DrugBank:DB01065	long COVID	Disease	MONDO:0100233	This narrative review discusses the application of melatonin as a neuroprotective agent to control cognitive deterioration ("brain fog") and pain in the ME/CFS syndrome-like documented in long COVID.	36358996	CustomKB
GNBR::T::Compound:Disease	long COVID	Disease	MONDO:0100233	Human immunoglobulin G	Compound	DrugBank:DB00028	IgG is highly effective for a proportion of patients with severe and well-characterised ME/CFS.	34828592	CustomKB
GNBR::T::Compound:Disease	Pulmonary Fibrosis	Disease	MONDO:0002771	Tetrandrine	Compound	DrugBank:DB14066	"TABLE 2 An overview of the symptoms, main pathophysiology, and potential interventions of the five proposed subtypes of the postCOVID‐19 syndrome (PCS)"	34888989	CustomKB
GNBR::T::Compound:Disease	Pulmonary Fibrosis	Disease	MONDO:0002771	Pirfenidone	Compound	DrugBank:DB04951	" TABLE 2 An overview of the symptoms, main pathophysiology, and potential interventions of the five proposed subtypes of the postCOVID‐19 syndrome (PCS)"	34888989	CustomKB
GNBR::T::Compound:Disease	Pulmonary Fibrosis	Disease	MONDO:0002771	Acetylcholine	Compound	DrugBank:DB03128	"TABLE 2 An overview of the symptoms, main pathophysiology, and potential interventions of the five proposed subtypes of the postCOVID‐19 syndrome (PCS)"	34888989	CustomKB
GNBR::T::Compound:Disease	long COVID	Disease	MONDO:0100233	Fenofibrate	Compound	DrugBank:DB01039	"Other drugs being studied for use in ME/CFS or Long COVID include metformin , fenofibrate (which is somewhat protective against reperfusion injury, and low-dose naltrexone."	36043493	CustomKB
GNBR::T::Compound:Disease	long COVID	Disease	MONDO:0100233	Naltrexone	Compound	DrugBank:DB00704	"Other drugs being studied for use in ME/CFS or Long COVID include metformin , fenofibrate (which is somewhat protective against reperfusion injury, and low-dose naltrexone."	36043493	CustomKB
GNBR::T::Compound:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	Metformin	Compound	DrugBank:DB00331	"Other drugs being studied for use in ME/CFS or Long COVID include metformin , fenofibrate (which is somewhat protective against reperfusion injury, and low-dose naltrexone."	36043493	CustomKB
GNBR::T::Compound:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	Fenofibrate	Compound	DrugBank:DB01039	" Other drugs being studied for use in ME/CFS or Long COVID include metformin , fenofibrate (which is somewhat protective against reperfusion injury, and low-dose naltrexone."	36043493	CustomKB
GNBR::T::Compound:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	Naltrexone	Compound	DrugBank:DB00704	"Other drugs being studied for use in ME/CFS or Long COVID include metformin , fenofibrate (which is somewhat protective against reperfusion injury, and low-dose naltrexone."	36043493	CustomKB
GNBR::T::Compound:Disease	long COVID	Disease	MONDO:0100233	Ergothioneine	Compound	MESH:D004880	"Consequently, ergothioneine has been proposed as a suitable antioxidant for use in COVID-19 amelioration."	36043493	CustomKB
GNBR::T::Compound:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	Hydrocortisone	Compound	DrugBank:DB00741	Low levels of cortisol have also been reported for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and treatment with hydrocortisone is reported to elicit modest improvement in symptoms.	35982667	CustomKB
GNBR::T::Compound:Disease	long COVID	Disease	MONDO:0100233	Butyrates	Compound	MESH:C475595	"Considering the role of microbiomederived butyrate in the gut–microbiota–brain axis , it is possible that butyrate could be a potential therapeutic short-chain fatty acids for long COVID."	37402856	CustomKB
GNBR::T::Compound:Disease	long COVID	Disease	MONDO:0100233	Fluvoxamine	Compound	DrugBank:DB00176	It is proposed that the potent sigma-1 receptor agonist fluvoxamine [a selective serotonin reuptake inhibitor (SSRI)] may be a potential therapeutic drug for long COVID.	37402856	CustomKB
GNBR::T::Compound:Disease	long COVID	Disease	MONDO:0100233	Clopidogrel	Compound	DrugBank:DB00758	Long COVID patients might be treated by one month of dual antiplatelet therapy (DAPT) (Clopidogrel 75 mg/Aspirin 75 mg) once a day.	35195253	CustomKB
GNBR::T::Compound:Disease	long COVID	Disease	MONDO:0100233	Nitroaspirin	Compound	DrugBank:DB12445	 Long COVID patients might be treated by one month of dual antiplatelet therapy (DAPT) (Clopidogrel 75 mg/Aspirin 75 mg) once a day.	35195253	CustomKB
GNBR::T::Compound:Disease	long COVID	Disease	MONDO:0100233	Pantoprazole	Compound	DrugBank:DB00213	Long COVID patients might be treated by one month of a proton pump inhibitor (PPI) (e.g. pantoprazole 40 mg/day for gastric protection).	35195253	CustomKB
GNBR::T::Compound:Disease	long COVID	Disease	MONDO:0100233	Omega-3 fatty acids	Compound	DrugBank:DB11133	Long chain omega-3 polyunsaturated fatty acids (omega-3 PUFAs) has therefore been suggested to deal with Long COVID.	35390469	CustomKB
GNBR::T::Compound:Disease	long COVID	Disease	MONDO:0100233	Ganciclovir	Compound	DrugBank:DB01004	"Ganciclovir, which inhibits replication of EBV and cytomegalovirus, has the potential to treat Long COVID."	35912863	CustomKB
GNBR::T::Compound:Disease	long COVID	Disease	MONDO:0100233	Amitriptyline	Compound	DrugBank:DB00321	"Treatment with amitriptyline can also help improve sleep quality, which can be particularly useful as long COVID headache is often accompanied by sleep disruptions."	35915417	CustomKB
GNBR::T::Compound:Disease	long COVID	Disease	MONDO:0100233	Indomethacin	Compound	DrugBank:DB00328	"Indomethacin(50  mg, BID) is effective in patients with long COVID headache."	35915417	CustomKB
GNBR::T::Compound:Disease	Postural Orthostatic Tachycardia Syndrome	Disease	MONDO:0011479	Ivabradine	Compound	DrugBank:DB09083	Betablockers and ivabradine were proposed in patients with post-orthostatic tachycardia syndrome (POTS). 	35647070	CustomKB
GNBR::T::Compound:Disease	long COVID	Disease	MONDO:0100233	Etanercept	Compound	DrugBank:DB00005	Etanercept has already been proposed as an argument for reversing the neurological aspects of long COVID-1962 and post-cerebral malaria cognitive impairment.	35174650	CustomKB
GNBR::T::Compound:Disease	long COVID	Disease	MONDO:0100233	zinc chloride	Compound	DrugBank:DB14533	These results suggest that EAT has potential as a novel method for long COVID treatment.	35632649	CustomKB
GNBR::T::Compound:Disease	ME/CFS	Disease	MONDO:0005404	zinc chloride	Compound	DrugBank:DB14533	These results suggest that EAT has potential as a novel method for long COVID treatment.	35632649	CustomKB
GNBR::X::Gene:Disease	bioactive 2-5A synthetase	Gene	ENTREZ:4938	CFS	Disease	MONDO:0005404	"The 2-5A synthetase/RNase L pathway in CFS patients appears to be both up-regulated (i.e. increased levels of bioactive 2-5A synthetase and increased activity of the RNase L enzyme) and deregulated (elastase and calpain initiate 83 kDa RNase L proteolysis, generating two major fragments with molecular masses of 37 and 30 kDa, respectively)."	16277015	CustomKB
Hetionet::CrC::Compound:Compound	Oxaloacetate Ion	Compound	DrugBank:DB02637	AMPK Signaling	Pathway	WikiPathways:WP1403	Oxaloacetate has been shown to increase glucose uptake in trials with diabetic patients and Alzheimer’s patients providing a mechanism to increase the amount of fuel available for cellular functions.	35764955	CustomKB
Hetionet::CrC::Compound:Compound	Oxaloacetate Ion	Compound	DrugBank:DB02637	Hydrogen peroxide	Compound	DrugBank:DB11091	"Oxaloacetate is a powerful antioxidant, reducing both thiobarbituric acid and hydrogen peroxide in the brain"	35764955	CustomKB
Hetionet::CrC::Compound:Compound	Oxaloacetate Ion	Compound	DrugBank:DB02637	Kainic Acid	Compound	MESH:D007608	Oxaloacetate also protects mitochondrial DNA from damage from agents such as Kainic acid.	35764955	CustomKB
Hetionet::CrC::Compound:Compound	Magnesium	Compound	DrugBank:DB14513	Vitamin D	Compound	DrugBank:DB11094	"Magnesium is necessary for the biosynthesis, transport, and activation of vitamin D."	35454144	CustomKB
Hetionet::CrC::Compound:Compound	Selenium	Compound	DrugBank:DB11135	Selenocysteine	Compound	DrugBank:DB02345	"Dietary selenium is converted in the body into aminoacid selenocysteine, which is important component of the antioxidant defense systems."	35454144	CustomKB
Hetionet::DaG::Disease:Gene	chronic fatigue syndrome	Disease	MONDO:0005404	S100PBP	Gene	ENTREZ:64766	Combinatorial analysis revealed 199 SNPs mapping to 14 genes that were significantly associated with 91% of the cases in the ME/CFS population.	36517845	CustomKB
Hetionet::DaG::Disease:Gene	chronic fatigue syndrome	Disease	MONDO:0005404	ATP9A	Gene	ENTREZ:10079	 Combinatorial analysis revealed 199 SNPs mapping to 14 genes that were significantly associated with 91% of the cases in the ME/CFS population.	36517845	CustomKB
Hetionet::DaG::Disease:Gene	chronic fatigue syndrome	Disease	MONDO:0005404	KCNB1	Gene	ENTREZ:3745	Combinatorial analysis revealed 199 SNPs mapping to 14 genes that were significantly associated with 91% of the cases in the ME/CFS population.	36517845	CustomKB
Hetionet::DaG::Disease:Gene	chronic fatigue syndrome	Disease	MONDO:0005404	CLOCK	Gene	ENTREZ:9575	Combinatorial analysis revealed 199 SNPs mapping to 14 genes that were significantly associated with 91% of the cases in the ME/CFS population.	36517845	CustomKB
Hetionet::DaG::Disease:Gene	chronic fatigue syndrome	Disease	MONDO:0005404	SLC15A4	Gene	ENTREZ:121260	Combinatorial analysis revealed 199 SNPs mapping to 14 genes that were significantly associated with 91% of the cases in the ME/CFS population.	36517845	CustomKB
Hetionet::DaG::Disease:Gene	chronic fatigue syndrome	Disease	MONDO:0005404	TMEM232	Gene	ENTREZ:642987	Combinatorial analysis revealed 199 SNPs mapping to 14 genes that were significantly associated with 91% of the cases in the ME/CFS population.	36517845	CustomKB
Hetionet::DaG::Disease:Gene	chronic fatigue syndrome	Disease	MONDO:0005404	GPC5	Gene	ENTREZ:2262	Combinatorial analysis revealed 199 SNPs mapping to 14 genes that were significantly associated with 91% of the cases in the ME/CFS population.	36517845	CustomKB
Hetionet::DaG::Disease:Gene	chronic fatigue syndrome	Disease	MONDO:0005404	PHACTR2	Gene	ENTREZ:9749	 Combinatorial analysis revealed 199 SNPs mapping to 14 genes that were significantly associated with 91% of the cases in the ME/CFS population.	36517845	CustomKB
Hetionet::DaG::Disease:Gene	chronic fatigue syndrome	Disease	MONDO:0005404	AKAP1	Gene	ENTREZ:8165	Combinatorial analysis revealed 199 SNPs mapping to 14 genes that were significantly associated with 91% of the cases in the ME/CFS population.	36517845	CustomKB
Hetionet::DaG::Disease:Gene	chronic fatigue syndrome	Disease	MONDO:0005404	USP6NL	Gene	ENTREZ:9712	Combinatorial analysis revealed 199 SNPs mapping to 14 genes that were significantly associated with 91% of the cases in the ME/CFS population.	36517845	CustomKB
Hetionet::DaG::Disease:Gene	chronic fatigue syndrome	Disease	MONDO:0005404	CDON	Gene	ENTREZ:50937	Combinatorial analysis revealed 199 SNPs mapping to 14 genes that were significantly associated with 91% of the cases in the ME/CFS population.	36517845	CustomKB
Hetionet::DaG::Disease:Gene	chronic fatigue syndrome	Disease	MONDO:0005404	INSR	Gene	ENTREZ:3643	Combinatorial analysis revealed 199 SNPs mapping to 14 genes that were significantly associated with 91% of the cases in the ME/CFS population.	36517845	CustomKB
Hetionet::DaG::Disease:Gene	chronic fatigue syndrome	Disease	MONDO:0005404	SULF2	Gene	ENTREZ:55959	Combinatorial analysis revealed 199 SNPs mapping to 14 genes that were significantly associated with 91% of the cases in the ME/CFS population.	36517845	CustomKB
Hetionet::DaG::Disease:Gene	chronic fatigue syndrome	Disease	MONDO:0005404	SLC6A11	Gene	ENTREZ:6538	Combinatorial analysis revealed 199 SNPs mapping to 14 genes that were significantly associated with 91% of the cases in the ME/CFS population.	36517845	CustomKB
Hetionet::DdG::Disease:Gene	IL-10	Gene	ENTREZ:3586	CFS/ME	Disease	MONDO:0005404	"Of the 27 cytokines examined, only IL-10 was significantly reduced in the CFS/ME patients in comparison to the controls."	25834308	CustomKB
Hetionet::DdG::Disease:Gene	IL-7	Gene	ENTREZ:3574	ME/CFS	Disease	MONDO:0005404	"In combination with previous data, our work suggests that the clustered reduction of IL-7, IL-16 and VEGF-A may have physiological relevance to ME/CFS disease."	26615570	CustomKB
Hetionet::DdG::Disease:Gene	IL-16	Gene	ENTREZ:3603	ME/CFS	Disease	MONDO:0005404	"In combination with previous data, our work suggests that the clustered reduction of IL-7, IL-16 and VEGF-A may have physiological relevance to ME/CFS disease."	26615570	CustomKB
Hetionet::DdG::Disease:Gene	VEGF-A	Gene	ENTREZ:7422	ME/CFS	Disease	MONDO:0005404	"In combination with previous data, our work suggests that the clustered reduction of IL-7, IL-16 and VEGF-A may have physiological relevance to ME/CFS disease."	26615570	CustomKB
Hetionet::DdG::Disease:Gene	Long-Covid	Disease	MONDO:0100233	neurotransmitter autoantibodies	Gene	ENTREZ:6532	"In patients that reported a significant improvement following two cycles of therapeutic apheresis, there was a significant reduction in neurotransmitter autoantibodies, lipids, and inflammatory markers."	37131073	CustomKB
Hetionet::DdG::Disease:Gene	fibrinogen	Gene	ENTREZ:2244	Long-Covid	Disease	MONDO:0100233	"In patients that reported a significant improvement following two cycles of therapeutic apheresis, there was a significant reduction in neurotransmitter autoantibodies, lipids, and inflammatory markers."	37131073	CustomKB
Hetionet::DdG::Disease:Gene	elastase	Gene	ENTREZ:1991	CFS	Disease	MONDO:0005404	"The 2-5A synthetase/RNase L pathway in CFS patients appears to be both up-regulated (i.e. increased levels of bioactive 2-5A synthetase and increased activity of the RNase L enzyme) and deregulated (elastase and calpain initiate 83 kDa RNase L proteolysis, generating two major fragments with molecular masses of 37 and 30 kDa, respectively)."	16277015	CustomKB
Hetionet::DdG::Disease:Gene	granulocyte-macrophage colony-stimulating factor	Gene	ENTREZ:1437	chronic fatigue syndrome	Disease	MONDO:0005404	levels of granulocyte-macrophage colony-stimulating factor were lower in patients than controls	15642984	CustomKB
Hetionet::DlA::Disease:Anatomy	muscle	Anatomy	MESH:D009132	ME/CFS	Disease	MONDO:0005404	"In ME/CFS patients, severe alterations of the muscle excitability, the redox status, as well as the CD26-expression level are correlated with a marked impairment of the quality-of-life."	27580693	CustomKB
Hetionet::DlA::Disease:Anatomy	pituitary gland	Anatomy	MESH:D010902	Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	suppression of the pituitary gland's pulsatile secretion of tropic hormones	33585528	CustomKB
Hetionet::DlA::Disease:Anatomy	lungs	Anatomy	MESH:D008168	long COVID	Disease	MONDO:0100233	"Postacute sequelae of SARS-CoV-2 infection (PASC) include injury to the lungs, heart, kidneys, and brain that may produce a variety of symptoms."	34175230	CustomKB
Hetionet::DlA::Disease:Anatomy	heart	Anatomy	MESH:D006321	long COVID	Disease	MONDO:0100233	"Postacute sequelae of SARS-CoV-2 infection (PASC) include injury to the lungs, heart, kidneys, and brain that may produce a variety of symptoms."	34175230	CustomKB
Hetionet::DlA::Disease:Anatomy	kidneys	Anatomy	MESH:D007668	long COVID	Disease	MONDO:0100233	"Postacute sequelae of SARS-CoV-2 infection (PASC) include injury to the lungs, heart, kidneys, and brain that may produce a variety of symptoms."	34175230	CustomKB
Hetionet::DlA::Disease:Anatomy	brain	Anatomy	MESH:D001921	long COVID	Disease	MONDO:0100233	"Postacute sequelae of SARS-CoV-2 infection (PASC) include injury to the lungs, heart, kidneys, and brain that may produce a variety of symptoms."	34175230	CustomKB
Hetionet::DlA::Disease:Anatomy	hypertension	Disease	MONDO:0005044	Pulmonary	Anatomy	MESH:D008168	"Pulmonary structural changes such as hypertension, embolism and fibrosis are common in long COVID."	35449732	CustomKB
Hetionet::DlA::Disease:Anatomy	Pulmonary	Anatomy	MESH:D008168	long COVID	Disease	MONDO:0100233	"Pulmonary structural changes such as hypertension, embolism and fibrosis are common in long COVID."	35449732	CustomKB
Hetionet::DlA::Disease:Anatomy	long COVID	Disease	MONDO:0100233	female gonad	Anatomy	UBERON:0000992	"LC may be associated with disruptions to the menstrual cycle, gonadal function, ovarian insufficiency, premature menopause, and fertility problems."	37234076	CustomKB
Hetionet::DlA::Disease:Anatomy	chronic fatigue syndrome	Disease	MONDO:0005404	kidney	Anatomy	UBERON:0002113	"CFS is a unique disorder in that it is often a multisystem disorder, causing direct damage to major organs such as the kidney, heart, and lungs [2]."	37128534	CustomKB
Hetionet::DlA::Disease:Anatomy	chronic fatigue syndrome	Disease	MONDO:0005404	heart	Anatomy	UBERON:0000948	"CFS is a unique disorder in that it is often a multisystem disorder, causing direct damage to major organs such as the kidney, heart, and lungs [2]."	37128534	CustomKB
Hetionet::DlA::Disease:Anatomy	chronic fatigue syndrome	Disease	MONDO:0005404	lung	Anatomy	UBERON:0002048	"CFS is a unique disorder in that it is often a multisystem disorder, causing direct damage to major organs such as the kidney, heart, and lungs [2]."	37128534	CustomKB
Hetionet::DlA::Disease:Anatomy	chronic fatigue syndrome	Disease	MONDO:0005404	brainstem	Anatomy	UBERON:0002298	Our study demonstrated an abnormal brainstem volume in both ME/CFS and long COVID consistent with the overlapping symptoms.	36937672	CustomKB
Hetionet::DlA::Disease:Anatomy	long COVID	Disease	MONDO:0100233	brainstem	Anatomy	UBERON:0002298	Our study demonstrated an abnormal brainstem volume in both ME/CFS and long COVID consistent with the overlapping symptoms.	36937672	CustomKB
Hetionet::DlA::Disease:Anatomy	long COVID	Disease	MONDO:0100233	ear	Anatomy	UBERON:0001690	"Multiple organ systems are affected, such as psychological or psychiatric (insomnia, anxiety and depression), neurological (cognitive impairments involving memory and concentration, headache, dizziness and peripheral neuropathy), ear, nose, and throat (rhinorrhoea, smell and taste alterations, earache, tinnitus, cough, and sore throat), respiratory (dyspnoea and cough), cardiovascular (chest pain, palpitations and tachycardia), gastrointestinal (abdominal pain, nausea and diarrhoea), generalised (chills, pain and fever) and musculoskeletal (fatigue, myalgia and joint pain)."	34888989	CustomKB
Hetionet::DlA::Disease:Anatomy	long COVID	Disease	MONDO:0100233	nose	Anatomy	UBERON:0000004	"Multiple organ systems are affected, such as psychological or psychiatric (insomnia, anxiety and depression), neurological (cognitive impairments involving memory and concentration, headache, dizziness and peripheral neuropathy), ear, nose, and throat (rhinorrhoea, smell and taste alterations, earache, tinnitus, cough, and sore throat), respiratory (dyspnoea and cough), cardiovascular (chest pain, palpitations and tachycardia), gastrointestinal (abdominal pain, nausea and diarrhoea), generalised (chills, pain and fever) and musculoskeletal (fatigue, myalgia and joint pain)."	34888989	CustomKB
Hetionet::DlA::Disease:Anatomy	long COVID	Disease	MONDO:0100233	muscle tissue	Anatomy	UBERON:0002385	" Multiple organ systems are affected, such as psychological or psychiatric (insomnia, anxiety and depression), neurological (cognitive impairments involving memory and concentration, headache, dizziness and peripheral neuropathy), ear, nose, and throat (rhinorrhoea, smell and taste alterations, earache, tinnitus, cough, and sore throat), respiratory (dyspnoea and cough), cardiovascular (chest pain, palpitations and tachycardia), gastrointestinal (abdominal pain, nausea and diarrhoea), generalised (chills, pain and fever) and musculoskeletal (fatigue, myalgia and joint pain)."	34888989	CustomKB
Hetionet::DlA::Disease:Anatomy	long COVID	Disease	MONDO:0100233	brainstem	Anatomy	UBERON:0002298	"The proposed PET metabolic pattern is easily identified upon visual interpretation in clinical routine for approximately one half of patients with suspected neurological long COVID, requiring special consideration for frontobasal paramedian regions, the brainstem and the cerebellum."	35320385	CustomKB
Hetionet::DlA::Disease:Anatomy	long COVID	Disease	MONDO:0100233	cerebellum	Anatomy	UBERON:0002037	"The proposed PET metabolic pattern is easily identified upon visual interpretation in clinical routine for approximately one half of patients with suspected neurological long COVID, requiring special consideration for frontobasal paramedian regions, the brainstem and the cerebellum."	35320385	CustomKB
Hetionet::DlA::Disease:Anatomy	long COVID	Disease	MONDO:0100233	vagus nerve	Anatomy	UBERON:0001759	"Given the crucial role of the vagus nerve in the gut–brain axis, the author proposes that VNS could be a potential therapeutic approach for long COVID through its potent antiinflammatory activity."	37402856	CustomKB
Hetionet::DlA::Disease:Anatomy	long COVID	Disease	MONDO:0100233	pons	Anatomy	UBERON:0000988	The main interesting finding of these cases is that long COVID marked by cognitive complaints and deficits can be associated at least with hypometabolic regions of the brainstem and more especially of the pons.	35290729	CustomKB
Hetionet::DlA::Disease:Anatomy	long COVID	Disease	MONDO:0100233	cerebellar cortex	Anatomy	UBERON:0002129	"In addition, we have recently shown that, in long COVID patients, cognitive impairment in hospitalized and non-hospitalized individuals could be associated with hypometabolic areas of the cingulate cortex without affecting the brainstem."	35290729	CustomKB
Hetionet::DlA::Disease:Anatomy	long COVID	Disease	MONDO:0100233	locus ceruleus	Anatomy	UBERON:0002148	"In conclusion, these findings could suggest that cognitive deficits observed in these Long COVID patients could partly originate from the dysfunction of the locus coeruleus."	35290729	CustomKB
Hetionet::DlA::Disease:Anatomy	long COVID	Disease	MONDO:0100233	trigeminal nerve	Anatomy	UBERON:0001645	Activation of the trigeminal nerve is thought to be responsible for the symptoms of Long COVID headache.	35915417	CustomKB
Hetionet::DlA::Disease:Anatomy	trigeminovascular	Anatomy	UBERON:0001645	Long COVID headache	Symptom	SYMP:0000504	Persistent activation of the immune system and trigeminovascular activation are thought to play a role.	35915417	CustomKB
Hetionet::DpS::Disease:Symptom	neurovascular dysregulation	Disease	MONDO:0043218	acute exercise intolerance	Symptom	SYMP:0019176	We suggest that treatable neurovascular dysregulation underlies acute exercise intolerance in ME/CFS.	35526605	CustomKB
Hetionet::DpS::Disease:Symptom	chronic fatigue syndrome	Disease	MONDO:0005404	Orthostatic Intolerance	Symptom	MESH:D054971	"The new criteria require substantial impairment in function accompanied by fatigue, PEM, unrefreshing sleep, and either cognitive impairment or orthostatic intolerance."	34454716	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	Fatigue	Symptom	SYMP:0019177	"These symptoms include fatigue, cognitive problems, headaches, disrupted sleep, myalgias and arthralgias, post-exertional malaise, orthostatic intolerance, tachyarrhythmias and gastrointestinal complaints such as diarrhea."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	Diarrhea	Symptom	SYMP:0000570	"These symptoms include fatigue, cognitive problems, headaches, disrupted sleep, myalgias and arthralgias, post-exertional malaise, orthostatic intolerance, tachyarrhythmias and gastrointestinal complaints such as diarrhea."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	Orthostatic Intolerance	Symptom	MESH:D054971	"These symptoms include fatigue, cognitive problems, headaches, disrupted sleep, myalgias and arthralgias, post-exertional malaise, orthostatic intolerance, tachyarrhythmias and gastrointestinal complaints such as diarrhea."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	Cough	Symptom	SYMP:0000614	"TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	malaise	Symptom	SYMP:0019176	"TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	Headache	Symptom	SYMP:0000504	"TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	Sleep Disorders	Symptom	SYMP:0000566	"TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	decreased appetite	Symptom	SYMP:0000245	"TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	palpitation	Symptom	SYMP:0000530	"TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	breathing problems	Symptom	SYMP:0000868	"TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	Nausea	Symptom	SYMP:0000458	"TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	Chills	Symptom	SYMP:0019174	"TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	rash	Symptom	SYMP:0000487	"TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	hair loss	Symptom	SYMP:0000440	"TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	chronic fatigue syndrome	Disease	MONDO:0005404	Tinnitus	Symptom	SYMP:0000393	"TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	chronic fatigue syndrome	Disease	MONDO:0005404	Fatigue	Symptom	SYMP:0019177	"TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	chronic fatigue syndrome	Disease	MONDO:0005404	Cough	Symptom	SYMP:0000614	"TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	chronic fatigue syndrome	Disease	MONDO:0005404	malaise	Symptom	SYMP:0019176	"TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	chronic fatigue syndrome	Disease	MONDO:0005404	Headache	Symptom	SYMP:0000504	"TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	chronic fatigue syndrome	Disease	MONDO:0005404	Sleep Disorders	Symptom	SYMP:0000566	"TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	chronic fatigue syndrome	Disease	MONDO:0005404	decreased appetite	Symptom	SYMP:0000245	" TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	chronic fatigue syndrome	Disease	MONDO:0005404	palpitation	Symptom	SYMP:0000530	"TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	chronic fatigue syndrome	Disease	MONDO:0005404	breathing problems	Symptom	SYMP:0000868	"TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	chronic fatigue syndrome	Disease	MONDO:0005404	Nausea	Symptom	SYMP:0000458	"TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	chronic fatigue syndrome	Disease	MONDO:0005404	Chills	Symptom	SYMP:0019174	"TABLE 3 Comparison of symptoms, ME/CFS, and Long COVID."	37342500	CustomKB
Hetionet::DpS::Disease:Symptom	chronic fatigue syndrome	Disease	MONDO:0005404	Pelvic Pain	Symptom	MESH:D017699	"See Figure 1 for a summary of the female reproductive conditions we review in Long COVID, ME/CFS, POTS, and EDS."	37234076	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	Neurogenic Inflammation	Symptom	MESH:D020078	" We believe the ME/CFS-like ongoing effects of Long COVID are arising by very similar mechanisms involving neuroinflammation, but likely with some unique signaling, resulting from the pathology of the initial SARS-CoV-2 infection."	35693009	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	chest tightness	Symptom	SYMP:0020032	The included long COVID studies are shown in Table 1.	33925784	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	Dyspnea	Symptom	SYMP:0019153	The included long COVID studies are shown in Table 1.	33925784	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	insomnia	Symptom	SYMP:0000571	"Multiple organ systems are affected, such as psychological or psychiatric (insomnia, anxiety and depression), neurological (cognitive impairments involving memory and concentration, headache, dizziness and peripheral neuropathy), ear, nose, and throat (rhinorrhoea, smell and taste alterations, earache, tinnitus, cough, and sore throat), respiratory (dyspnoea and cough), cardiovascular (chest pain, palpitations and tachycardia), gastrointestinal (abdominal pain, nausea and diarrhoea), generalised (chills, pain and fever) and musculoskeletal (fatigue, myalgia and joint pain)."	34888989	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	anxiety	Symptom	SYMP:0000412	"Multiple organ systems are affected, such as psychological or psychiatric (insomnia, anxiety and depression), neurological (cognitive impairments involving memory and concentration, headache, dizziness and peripheral neuropathy), ear, nose, and throat (rhinorrhoea, smell and taste alterations, earache, tinnitus, cough, and sore throat), respiratory (dyspnoea and cough), cardiovascular (chest pain, palpitations and tachycardia), gastrointestinal (abdominal pain, nausea and diarrhoea), generalised (chills, pain and fever) and musculoskeletal (fatigue, myalgia and joint pain)."	34888989	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	depression	Symptom	SYMP:0000022	"Multiple organ systems are affected, such as psychological or psychiatric (insomnia, anxiety and depression), neurological (cognitive impairments involving memory and concentration, headache, dizziness and peripheral neuropathy), ear, nose, and throat (rhinorrhoea, smell and taste alterations, earache, tinnitus, cough, and sore throat), respiratory (dyspnoea and cough), cardiovascular (chest pain, palpitations and tachycardia), gastrointestinal (abdominal pain, nausea and diarrhoea), generalised (chills, pain and fever) and musculoskeletal (fatigue, myalgia and joint pain)."	34888989	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	Chest Pain	Symptom	SYMP:0000576	"Multiple organ systems are affected, such as psychological or psychiatric (insomnia, anxiety and depression), neurological (cognitive impairments involving memory and concentration, headache, dizziness and peripheral neuropathy), ear, nose, and throat (rhinorrhoea, smell and taste alterations, earache, tinnitus, cough, and sore throat), respiratory (dyspnoea and cough), cardiovascular (chest pain, palpitations and tachycardia), gastrointestinal (abdominal pain, nausea and diarrhoea), generalised (chills, pain and fever) and musculoskeletal (fatigue, myalgia and joint pain)."	34888989	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	palpitation	Symptom	SYMP:0000530	"Multiple organ systems are affected, such as psychological or psychiatric (insomnia, anxiety and depression), neurological (cognitive impairments involving memory and concentration, headache, dizziness and peripheral neuropathy), ear, nose, and throat (rhinorrhoea, smell and taste alterations, earache, tinnitus, cough, and sore throat), respiratory (dyspnoea and cough), cardiovascular (chest pain, palpitations and tachycardia), gastrointestinal (abdominal pain, nausea and diarrhoea), generalised (chills, pain and fever) and musculoskeletal (fatigue, myalgia and joint pain)."	34888989	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	tachycardia	Symptom	SYMP:0000529	"Multiple organ systems are affected, such as psychological or psychiatric (insomnia, anxiety and depression), neurological (cognitive impairments involving memory and concentration, headache, dizziness and peripheral neuropathy), ear, nose, and throat (rhinorrhoea, smell and taste alterations, earache, tinnitus, cough, and sore throat), respiratory (dyspnoea and cough), cardiovascular (chest pain, palpitations and tachycardia), gastrointestinal (abdominal pain, nausea and diarrhoea), generalised (chills, pain and fever) and musculoskeletal (fatigue, myalgia and joint pain)."	34888989	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	disorientation	Symptom	SYMP:0000023	"Brain fog, or disorientation, forgetfulness, inability to focus, exhaustion, and poor mental energy, is, therefore, an important developing consequence of COVID-19 infection."	36358996	CustomKB
Hetionet::DpS::Disease:Symptom	Headache	Symptom	SYMP:0000504	Migraine Disorders	Disease	MONDO:0005277	Some migrainelike features of the headache during the acute phase were associated with long COVID headache.	35915417	CustomKB
Hetionet::DpS::Disease:Symptom	Headache	Symptom	SYMP:0000504	Hypercapnia	Disease	MESH:D006935	The first theories that were considered regarding COVID-19 headache pathophysiology was hypercapnia.	35915417	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	palpitation	Symptom	SYMP:0000530	"Long-COVID-19 syndrome was characterized by a combination of non-specific symptoms, especially chest pain and palpitations."	35647070	CustomKB
Hetionet::DpS::Disease:Symptom	long COVID	Disease	MONDO:0100233	Chest Pain	Symptom	SYMP:0000576	" Long-COVID-19 syndrome was characterized by a combination of non-specific symptoms, especially chest pain and palpitations."	35647070	CustomKB
Hetionet::DrD::Disease:Disease	delayed orthostatic hypotension (dOH)	Disease	MONDO:0005469	chronic fatigue syndrome/myalgic encephalomyelitis (ME/CFS)	Disease	MONDO:0005404	"During HUT, extracranial Doppler measurements demonstrate that CBF is reduced in ME/CFS patients with POTS, dOH, and even in those without HR/BP abnormalities."	32140630	CustomKB
Hetionet::DrD::Disease:Disease	postural orthostatic tachycardia syndrome (POTS)	Disease	MONDO:0011479	chronic fatigue syndrome/myalgic encephalomyelitis (ME/CFS)	Disease	MONDO:0005404	"During HUT, extracranial Doppler measurements demonstrate that CBF is reduced in ME/CFS patients with POTS, dOH, and even in those without HR/BP abnormalities."	32140630	CustomKB
Hetionet::DrD::Disease:Disease	postural tachycardia syndrome	Disease	MONDO:0011479	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"These include neuromuscular limitations that could be treated with manual forms of therapy, orthostatic intolerance and POTS for which there are multiple medications and non-pharmacologic therapies, treatable allergic and mast cell phenomena, and neurologic abnormalities that may require specific treatment."	33996867	CustomKB
Hetionet::DrD::Disease:Disease	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	long COVID	Disease	MONDO:0100233	"Here we summarize what is known about the pathogenesis of ME/CFS and of 'acute' COVID-19, and we speculate that the pathogenesis of post-COVID-19 syndrome in some people may be similar to that of ME/CFS."	34175230	CustomKB
Hetionet::DrD::Disease:Disease	ME/CFS	Disease	MONDO:0005404	long COVID	Disease	MONDO:0100233	"In addition, there was a striking similarity in symptoms between long COVID and ME/CFS, suggesting that studies on the mechanism and treatment of ME/CFS may help prevent and treat long COVID and vice versa."	34682970	CustomKB
Hetionet::DrD::Disease:Disease	ME/CFS	Disease	MONDO:0005404	COVID-19	Disease	MONDO:0100096	"We discuss the implications of COVID-19, which has much in common with ME/CFS, with much overlap of symptoms, and propose a new taxonomic category, which we are terming post-active phase of infection syndromes (PAPIS) to include both."	34684049	CustomKB
Hetionet::DrD::Disease:Disease	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	heat stroke	Disease	MESH:D018883	We here provide an overview of the pathophysiological mechanisms during heat stroke and describe similar mechanisms found in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).	34966354	CustomKB
Hetionet::DrD::Disease:Disease	hyperhomocysteinemia	Disease	MONDO:0004743	Long COVID	Disease	MONDO:0100233	"Therefore, the incorporation of hyperhomocysteinemia will be discussed in relation to impaired FOCM in each of the previously listed clinical diseases."	35056324	CustomKB
Hetionet::DrD::Disease:Disease	long-haul COVID-19	Disease	MONDO:0100233	postural tachycardia syndrome (POTS)	Disease	MONDO:0011479	All long-haul COVID-19 patients developed POTS during tilt.	35056336	CustomKB
Hetionet::DrD::Disease:Disease	asthma bronchiale	Disease	MONDO:0004979	long COVID	Disease	MONDO:0100233	"We discover an immunoglobulin (Ig) signature, based on total IgM and IgG3 levels, which - combined with age, history of asthma bronchiale, and five symptoms during primary infection - is able to predict the risk of PACS independently of timepoint of blood sampling."	35078982	CustomKB
Hetionet::DrD::Disease:Disease	type 2 diabetes	Disease	MONDO:0005148	Post-acute sequelae of COVID-19 (PASC)	Disease	MONDO:0100233	"We resolved four PASC-anticipating risk factors at the time of initial COVID-19 diagnosis: type 2 diabetes, SARS-CoV-2 RNAemia, Epstein-Barr virus viremia, and specific auto-antibodies."	35216672	CustomKB
Hetionet::DrD::Disease:Disease	SARS-CoV-2 RNAemia	Disease	MONDO:0100318	Post-acute sequelae of COVID-19 (PASC)	Disease	MONDO:0100233	"We resolved four PASC-anticipating risk factors at the time of initial COVID-19 diagnosis: type 2 diabetes, SARS-CoV-2 RNAemia, Epstein-Barr virus viremia, and specific auto-antibodies."	35216672	CustomKB
Hetionet::DrD::Disease:Disease	Epstein-Barr virus viremia	Disease	MONDO:0005111	Post-acute sequelae of COVID-19 (PASC)	Disease	MONDO:0100233	"We resolved four PASC-anticipating risk factors at the time of initial COVID-19 diagnosis: type 2 diabetes, SARS-CoV-2 RNAemia, Epstein-Barr virus viremia, and specific auto-antibodies."	35216672	CustomKB
Hetionet::DrD::Disease:Disease	long COVID	Disease	MONDO:0100233	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"Because some presentations of post-COVID-19 conditions mimic disorders such as ME/CFS, treatment guidelines for this and related conditions can be helpful for managing post-COVID-19 symptoms."	35287333	CustomKB
Hetionet::DrD::Disease:Disease	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	infectious mononucleosis (IM)	Disease	MONDO:0005810	"From analyses using receiver operating characteristic statistics, the students who had had severe gastrointestinal symptoms of stomach pain, bloating, and an irritable bowel at baseline and who also had abnormally low levels of the immune markers IL-13 and/or IL-5 at baseline, as well as severe gastrointestinal symptoms when then contracted IM, were found to have a nearly 80% chance of having severe ME/CFS persisting six months following IM."	35350440	CustomKB
Hetionet::DrD::Disease:Disease	hypertension	Disease	MONDO:0005044	long COVID	Disease	MONDO:0100233	"Pulmonary structural changes such as hypertension, embolism and fibrosis are common in long COVID."	35449732	CustomKB
Hetionet::DrD::Disease:Disease	idiopathic intracranial hypertension (IIH)	Disease	MONDO:0006810	chronic fatigue syndrome	Disease	MONDO:0005404	Recognition of similarities between chronic fatigue syndrome and idiopathic intracranial hypertension (IIH) has raised suggestions that they might be connected	37064208	CustomKB
Hetionet::DrD::Disease:Disease	orthostatic intolerance (OI)	Disease	MONDO:0005469	ME/CFS	Disease	MONDO:0005404	OI symptomatology and objective abnormalities of OI (abnormal cerebral blood flow and cardiac index reduction during tilt testing) are comparable to those in ME/CFS patients.	36292504	CustomKB
Hetionet::DrD::Disease:Disease	long-haul COVID	Disease	MONDO:0100233	ME/CFS	Disease	MONDO:0005404	It indicates that long-haul COVID is essentially the same disease as ME/CFS.	36292504	CustomKB
Hetionet::DrD::Disease:Disease	microvascular endotheliopathy	Disease	MONDO:0044875	long COVID	Disease	MONDO:0100233	Persistent microvascular endotheliopathy associated with cryptic SARS-CoV-2 tissue reservoirs has been implicated in PASC pathology.	35912863	CustomKB
Hetionet::DrD::Disease:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	Polycystic Ovary Syndrome	Disease	MONDO:0008487	"See Figure 1 for a summary of the female reproductive conditions we review in Long COVID, ME/CFS, POTS, and EDS."	37234076	CustomKB
Hetionet::DrD::Disease:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	Dysmenorrhea	Disease	MESH:D004412	"Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is often associated with various other syndromes or conditions including mast cell activation (MCA), dysmenorrhea and endometriosis, postural tachycardia (POTS) and small fiber neuropathy (SFN)."	37241210	CustomKB
Hetionet::DrD::Disease:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	Endometriosis	Disease	MONDO:0005133	"Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is often associated with various other syndromes or conditions including mast cell activation (MCA), dysmenorrhea and endometriosis, postural tachycardia (POTS) and small fiber neuropathy (SFN)."	37241210	CustomKB
Hetionet::DrD::Disease:Disease	long COVID	Disease	MONDO:0100233	Primary Ovarian Insufficiency	Disease	MONDO:0005387	"LC may be associated with disruptions to the menstrual cycle, gonadal function, ovarian insufficiency, premature menopause, and fertility problems."	37234076	CustomKB
Hetionet::DrD::Disease:Disease	long COVID	Disease	MONDO:0100233	Endometriosis	Disease	MONDO:0005133	"See Figure 1 for a summary of the female reproductive conditions we review in Long COVID, ME/CFS, POTS, and EDS."	37234076	CustomKB
Hetionet::DrD::Disease:Disease	long COVID	Disease	MONDO:0100233	Amenorrhea	Disease	MONDO:0001836	"See Figure 1 for a summary of the female reproductive conditions we review in Long COVID, ME/CFS, POTS, and EDS."	37234076	CustomKB
Hetionet::DrD::Disease:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	Amenorrhea	Disease	MONDO:0001836	"See Figure 1 for a summary of the female reproductive conditions we review in Long COVID, ME/CFS, POTS, and EDS."	37234076	CustomKB
Hetionet::DrD::Disease:Disease	long COVID	Disease	MONDO:0100233	Oligomenorrhea	Disease	MESH:D009839	"See Figure 1 for a summary of the female reproductive conditions we review in Long COVID, ME/CFS, POTS, and EDS."	37234076	CustomKB
Hetionet::DrD::Disease:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	Oligomenorrhea	Disease	MESH:D009839	"See Figure 1 for a summary of the female reproductive conditions we review in Long COVID, ME/CFS, POTS, and EDS."	37234076	CustomKB
Hetionet::DrD::Disease:Disease	long COVID	Disease	MONDO:0100233	Premenstrual Syndrome	Disease	MONDO:0004169	"See Figure 1 for a summary of the female reproductive conditions we review in Long COVID, ME/CFS, POTS, and EDS."	37234076	CustomKB
Hetionet::DrD::Disease:Disease	long COVID	Disease	MONDO:0100233	ovarian dysfunction	Disease	MONDO:0001889	"See Figure 1 for a summary of the female reproductive conditions we review in Long COVID, ME/CFS, POTS, and EDS."	37234076	CustomKB
Hetionet::DrD::Disease:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	Ovarian Cysts	Disease	MONDO:0003282	"See Figure 1 for a summary of the female reproductive conditions we review in Long COVID, ME/CFS, POTS, and EDS."	37234076	CustomKB
Hetionet::DrD::Disease:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	premature menopause	Disease	MONDO:0001119	"See Figure 1 for a summary of the female reproductive conditions we review in Long COVID, ME/CFS, POTS, and EDS."	37234076	CustomKB
Hetionet::DrD::Disease:Disease	long COVID	Disease	MONDO:0100233	Pulmonary Fibrosis	Disease	MONDO:0002771	"TABLE 2 An overview of the symptoms, main pathophysiology, and potential interventions of the five proposed subtypes of the postCOVID‐19 syndrome (PCS)"	34888989	CustomKB
Hetionet::DrD::Disease:Disease	long COVID	Disease	MONDO:0100233	Parkinson Disease	Disease	MONDO:0005180	"However, patients of Long COVID had about a 40% higher risk of developing cerebrovascular or neurodegenerative disorders (eg, ischaemic and haemorrhagic stroke, or Alzheimer’s disease or Parkinson’s-like disease) than did controls without SARS-CoV-2 infection."	37475126	CustomKB
Hetionet::DrD::Disease:Disease	long COVID	Disease	MONDO:0100233	Neurodegenerative Diseases	Disease	MONDO:0005559	"However, patients of Long COVID had about a 40% higher risk of developing cerebrovascular or neurodegenerative disorders (eg, ischaemic and haemorrhagic stroke, or Alzheimer’s disease or Parkinson’s-like disease) than did controls without SARS-CoV-2 infection."	37475126	CustomKB
Hetionet::DrD::Disease:Disease	long COVID	Disease	MONDO:0100233	Myocarditis	Disease	MONDO:0004496	Some evidence indicates that males between 12 and 17 years of age most likely developed myocarditis within 3 months of SARS-CoV-2 infection	36071155	CustomKB
Hetionet::DrD::Disease:Disease	Guillain-Barre Syndrome	Disease	MONDO:0016218	long COVID	Disease	MONDO:0100233	"These cases are consistent with conditions related to various forms of GuillainBarré syndrome (GBS), probably caused by autoimmunity, thus different from other sensory disfunctions seen in Covid-19, such as anosmia and dysgeusia, which seem to reflect a direct viral infiltration of the nervous system."	36071155	CustomKB
Hetionet::DrD::Disease:Disease	long COVID	Disease	MONDO:0100233	Obesity	Disease	MONDO:0011122	"For example, lipid metabolism disorders and obesity were found to be age-independent risk factors for the development of Long COVID, as shown in a retrospective study involving more than 50.000 patients with a confirmed diagnosis of Covid-19 treated by general practitioners in Germany."	36071155	CustomKB
Hetionet::DrD::Disease:Disease	long COVID	Disease	MONDO:0100233	Asthma	Disease	MONDO:0004979	The relationship between asthma and long COVID (LC28) deserves further investigation	33692530	CustomKB
Hetionet::DrD::Disease:Disease	long COVID	Disease	MONDO:0100233	Epiglottitis	Disease	MONDO:0005753	Chronic epipharyngitis/epiglottitis is frequently present in patients with long COVID.	35632649	CustomKB
Hetionet::DrD::Disease:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	Epiglottitis	Disease	MONDO:0005753	The diagnostic criteria for ME/CFS include a sore throat that can occur with chronic epipharyngitis/epiglottitis.	35632649	CustomKB
Hetionet::DrD::Disease:Disease	chronic fatigue syndrome	Disease	MONDO:0005404	Amyloidosis	Disease	MONDO:0019065	Amyloidosis into the blood vessels might be occurring throughout ME/CFS patients’ brains.	16321154	CustomKB
Hetionet::DrD::Disease:Disease	long COVID	Disease	MONDO:0100233	Hyperhomocysteinemia	Disease	MONDO:0004743	Long COVID may be associated with an elevation of the biomarker homocysteine(Hcy) with resulting hyperhomocysteinemia (HHcy).	35056324	CustomKB
Hetionet::DrD::Disease:Disease	long COVID	Disease	MONDO:0100233	Hypoxia	Disease	MESH:D000860	Long-COVID pathogenesis may be explained by the combined effect of chronic hypoxia.	35449732	CustomKB
Hetionet::DrD::Disease:Disease	long COVID	Disease	MONDO:0100233	pulmonary hypertension	Disease	MONDO:0005149	Pulmonary hypertension is common in long COVID resulting in impaired lung function.	35449732	CustomKB
Hetionet::DrD::Disease:Disease	long COVID	Disease	MONDO:0100233	pulmonary embolism	Disease	MONDO:0005279	Pulmonary embolismis common in long COVID resulting in impaired lung function.	35449732	CustomKB
Hetionet::DrD::Disease:Disease	long COVID	Disease	MONDO:0100233	pulmonary fibrosis	Disease	MONDO:0002771	 Pulmonary embolismis common in long COVID resulting in impaired lung function.	35449732	CustomKB
Hetionet::DrD::Disease:Disease	long COVID	Disease	MONDO:0100233	thrombosis	Disease	MONDO:0000831	Long COVID is essentially a thrombotic sequela.	35449732	CustomKB
Hetionet::DrD::Disease:Disease	long COVID	Disease	MONDO:0100233	chronic fatigue syndrome	Disease	MONDO:0005404	"Given the findings of comparable symptoms, hemodynamic, and cerebral blood flow abnormalities in long-haul COVID-19 and ME/CFS patients, our data support the notion that SARS-CoV-2 infection acts as a trigger for the development of ME/CFS in long-haul COVID-19 patients."	35056336	CustomKB
Hetionet::DrD::Disease:Disease	SARS Virus	Disease	MONDO:0005091	long COVID	Disease	MONDO:0100233	" Given the findings of comparable symptoms, hemodynamic, and cerebral blood flow abnormalities in long-haul COVID-19 and ME/CFS patients, our data support the notion that SARS-CoV-2 infection acts as a trigger for the development of ME/CFS in long-haul COVID-19 patients."	35056336	CustomKB
Hetionet::DrD::Disease:Disease	COVID-19 sequelae	Disease	MONDO:0100096	respiratory muscle dysfunction	Disease	MONDO:0013452	Our findings point towards respiratory muscle dysfunction as a novel aspect of COVID-19 sequelae.	35570238	CustomKB
Hetionet::DuG::Disease:Gene	TNF-α	Gene	ENTREZ:7124	CFS/ME	Disease	MONDO:0005404	"Interestingly, following mitogenic stimulation, cytokine secretion revealed significant increases in IL-10, IFN-γ and TNF-α at T1 in the CFS/ME group."	22571715	CustomKB
Hetionet::DuG::Disease:Gene	IL-17A	Gene	ENTREZ:3605	CFS/ME	Disease	MONDO:0005404	"A significant decrease was observed at T2 in the CFS/ME group for IL-10 and IL-17A while at T3, IL-2 was increased in the CFS/ME group in comparison to the non-fatigued controls."	22571715	CustomKB
Hetionet::DuG::Disease:Gene	IL-2	Gene	ENTREZ:3558	CFS/ME	Disease	MONDO:0005404	"A significant decrease was observed at T2 in the CFS/ME group for IL-10 and IL-17A while at T3, IL-2 was increased in the CFS/ME group in comparison to the non-fatigued controls."	22571715	CustomKB
Hetionet::DuG::Disease:Gene	iNKT CD62L	Gene	ENTREZ:6402	CFS/ME	Disease	MONDO:0005404	"Over time, iNKT CD62L expression significantly increased in moderate CFS/ME patients and CD56(bright) NK receptors differed in severe CFS/ME."	26370228	CustomKB
Hetionet::DuG::Disease:Gene	CD57	Gene	ENTREZ:27087	CFS/ME	Disease	MONDO:0005404	Co-expression of CD57 and perforin was significantly increased on CD56(dim) CD16(+) NK cells from patients with CFS/ME compared to the MS and non-fatigued control participants.	26381393	CustomKB
Hetionet::DuG::Disease:Gene	perforin	Gene	ENTREZ:5551	CFS/ME	Disease	MONDO:0005404	Co-expression of CD57 and perforin was significantly increased on CD56(dim) CD16(+) NK cells from patients with CFS/ME compared to the MS and non-fatigued control participants.	26381393	CustomKB
Hetionet::DuG::Disease:Gene	fractalkine (CX3CL1)	Gene	ENTREZ:6376	ME/CFS	Disease	MONDO:0005404	"In addition, we identified significant reductions in the concentrations of fractalkine (CX3CL1) and monokine-induced-by-IFN-γ (MIG; CXCL9) along with increases in the concentrations of eotaxin 2 (CCL24) in ME/CFS patients."	26615570	CustomKB
Hetionet::DuG::Disease:Gene	monokine-induced-by-IFN-γ (MIG; CXCL9)	Gene	ENTREZ:4283	ME/CFS	Disease	MONDO:0005404	"In addition, we identified significant reductions in the concentrations of fractalkine (CX3CL1) and monokine-induced-by-IFN-γ (MIG; CXCL9) along with increases in the concentrations of eotaxin 2 (CCL24) in ME/CFS patients."	26615570	CustomKB
Hetionet::DuG::Disease:Gene	eotaxin 2 (CCL24)	Gene	ENTREZ:6369	ME/CFS	Disease	MONDO:0005404	"In addition, we identified significant reductions in the concentrations of fractalkine (CX3CL1) and monokine-induced-by-IFN-γ (MIG; CXCL9) along with increases in the concentrations of eotaxin 2 (CCL24) in ME/CFS patients."	26615570	CustomKB
Hetionet::DuG::Disease:Gene	ATP synthase subunit beta (ATPB)	Gene	ENTREZ:506	Chronic fatigue syndrome (CFS)	Disease	MONDO:0005404	Results for ATPB and ACON confirmed their upregulation in CFS.	27676445	CustomKB
Hetionet::DuG::Disease:Gene	aconitate hydratase (ACON)	Gene	ENTREZ:48	Chronic fatigue syndrome (CFS)	Disease	MONDO:0005404	Results for ATPB and ACON confirmed their upregulation in CFS.	27676445	CustomKB
Hetionet::DuG::Disease:Gene	glial fibrillary acidic protein	Gene	ENTREZ:2670	long COVID	Disease	MONDO:0100233	"Moreover, long COVID patients with neurological symptoms exhibited higher levels of neurofilament light chain and glial fibrillary acidic protein whereas those with pulmonary symptoms exhibited a higher level of transforming growth factor beta."	36744129	CustomKB
Hetionet::DuG::Disease:Gene	transforming growth factor beta	Gene	ENTREZ:7040	long COVID	Disease	MONDO:0100233	"Moreover, long COVID patients with neurological symptoms exhibited higher levels of neurofilament light chain and glial fibrillary acidic protein whereas those with pulmonary symptoms exhibited a higher level of transforming growth factor beta."	36744129	CustomKB
Hetionet::DuG::Disease:Gene	interleukin-8 (IL-8)	Gene	ENTREZ:3576	chronic fatigue syndrome	Disease	MONDO:0005404	"levels of interleukin-8 (IL-8) were higher in patients with sudden, influenza-like onset than in patients with gradual onset or in controls"	15642984	CustomKB
Hetionet::DuG::Disease:Gene	IL-10	Gene	ENTREZ:3586	chronic fatigue syndrome	Disease	MONDO:0005404	IL-10 levels were higher in the patients with abnormal spinal fluids than in those with normal fluid or controls	15642984	CustomKB
Hetionet::DuG::Disease:Gene	IL-10	Gene	ENTREZ:3586	CFS/ME	Disease	MONDO:0005404	"Interestingly, following mitogenic stimulation, cytokine secretion revealed significant increases in IL-10, IFN-γ and TNF-α at T1 in the CFS/ME group."	22571715	CustomKB
Hetionet::DuG::Disease:Gene	IFN-γ	Gene	ENTREZ:3458	CFS/ME	Disease	MONDO:0005404	"Interestingly, following mitogenic stimulation, cytokine secretion revealed significant increases in IL-10, IFN-γ and TNF-α at T1 in the CFS/ME group."	22571715	CustomKB
Hetionet::GiG::Gene:Gene	sRAGE	Gene	ENTREZ:177	TNF-α	Gene	ENTREZ:7124	"Furthermore, we observed statistically significant correlations between the advanced glycation end product (sRAGE) and TNF-α (Pearson's factor R = 0.637; p < 0.001) and between serum levels of DNM1L and IFN-α (Pearson's factor R = 0.501; p = 0.002) in P(+) patients."	37445288	CustomKB
HSDN::has_symptom::Disease:Symptom	orthostatic intolerance	Symptom	MESH:D054971	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"In a study of 429 adults with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), we demonstrated that 86% had symptoms of orthostatic intolerance in daily life."	32545797	CustomKB
HSDN::has_symptom::Disease:Symptom	fatigue	Symptom	SYMP:0019177	Long COVID	Disease	MONDO:0005404	"Long COVID was characterized by symptoms of fatigue, headache, dyspnea and anosmia and was more likely with increasing age and body mass index and female sex."	33692530	CustomKB
HSDN::has_symptom::Disease:Symptom	headache	Symptom	MESH:D006261	Long COVID	Disease	MONDO:0005404	"Long COVID was characterized by symptoms of fatigue, headache, dyspnea and anosmia and was more likely with increasing age and body mass index and female sex."	33692530	CustomKB
HSDN::has_symptom::Disease:Symptom	dyspnea	Symptom	SYMP:0019153	Long COVID	Disease	MONDO:0005404	"Long COVID was characterized by symptoms of fatigue, headache, dyspnea and anosmia and was more likely with increasing age and body mass index and female sex."	33692530	CustomKB
HSDN::has_symptom::Disease:Symptom	anosmia	Symptom	SYMP:0000551	Long COVID	Disease	MONDO:0005404	"Long COVID was characterized by symptoms of fatigue, headache, dyspnea and anosmia and was more likely with increasing age and body mass index and female sex."	33692530	CustomKB
HSDN::has_symptom::Disease:Symptom	anaemia	Symptom	SYMP:0000208	post-acute sequelae	Disease	MONDO:0100233	"Our high-dimensional approach identifies incident sequelae in the respiratory system, as well as several other sequelae that include nervous system and neurocognitive disorders, mental health disorders, metabolic disorders, cardiovascular disorders, gastrointestinal disorders, malaise, fatigue, musculoskeletal pain and anaemia."	33887749	CustomKB
HSDN::has_symptom::Disease:Symptom	malaise	Symptom	SYMP:0019176	post-acute sequelae	Disease	MONDO:0100233	"Our high-dimensional approach identifies incident sequelae in the respiratory system, as well as several other sequelae that include nervous system and neurocognitive disorders, mental health disorders, metabolic disorders, cardiovascular disorders, gastrointestinal disorders, malaise, fatigue, musculoskeletal pain and anaemia."	33887749	CustomKB
HSDN::has_symptom::Disease:Symptom	fatigue	Symptom	SYMP:0019177	post-acute sequelae	Disease	MONDO:0100233	"Our high-dimensional approach identifies incident sequelae in the respiratory system, as well as several other sequelae that include nervous system and neurocognitive disorders, mental health disorders, metabolic disorders, cardiovascular disorders, gastrointestinal disorders, malaise, fatigue, musculoskeletal pain and anaemia."	33887749	CustomKB
HSDN::has_symptom::Disease:Symptom	musculoskeletal pain	Symptom	MESH:D059352	post-acute sequelae	Disease	MONDO:0100233	"Our high-dimensional approach identifies incident sequelae in the respiratory system, as well as several other sequelae that include nervous system and neurocognitive disorders, mental health disorders, metabolic disorders, cardiovascular disorders, gastrointestinal disorders, malaise, fatigue, musculoskeletal pain and anaemia."	33887749	CustomKB
HSDN::has_symptom::Disease:Symptom	allergic	Symptom	SYMP:0000900	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"These include neuromuscular limitations that could be treated with manual forms of therapy, orthostatic intolerance and POTS for which there are multiple medications and non-pharmacologic therapies, treatable allergic and mast cell phenomena, and neurologic abnormalities that may require specific treatment."	33996867	CustomKB
HSDN::has_symptom::Disease:Symptom	orthostatic intolerance	Symptom	MESH:D054971	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"These include neuromuscular limitations that could be treated with manual forms of therapy, orthostatic intolerance and POTS for which there are multiple medications and non-pharmacologic therapies, treatable allergic and mast cell phenomena, and neurologic abnormalities that may require specific treatment."	33996867	CustomKB
HSDN::has_symptom::Disease:Symptom	profound fatigue	Symptom	SYMP:0019177	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"ME/CFS is a debilitating condition, often triggered by viral and bacterial infections, leading to years-long debilitating symptoms including profound fatigue, postexertional malaise, unrefreshing sleep, cognitive deficits, and orthostatic intolerance."	34400495	CustomKB
HSDN::has_symptom::Disease:Symptom	postexertional malaise	Symptom	SYMP:0019176	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"ME/CFS is a debilitating condition, often triggered by viral and bacterial infections, leading to years-long debilitating symptoms including profound fatigue, postexertional malaise, unrefreshing sleep, cognitive deficits, and orthostatic intolerance."	34400495	CustomKB
HSDN::has_symptom::Disease:Symptom	unrefreshing sleep	Symptom	SYMP:0000566	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"ME/CFS is a debilitating condition, often triggered by viral and bacterial infections, leading to years-long debilitating symptoms including profound fatigue, postexertional malaise, unrefreshing sleep, cognitive deficits, and orthostatic intolerance."	34400495	CustomKB
HSDN::has_symptom::Disease:Symptom	orthostatic intolerance	Symptom	MESH:D054971	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"ME/CFS is a debilitating condition, often triggered by viral and bacterial infections, leading to years-long debilitating symptoms including profound fatigue, postexertional malaise, unrefreshing sleep, cognitive deficits, and orthostatic intolerance."	34400495	CustomKB
HSDN::has_symptom::Disease:Symptom	fatigue	Symptom	SYMP:0019177	ME/CFS	Disease	MONDO:0005404	"The observed sex-specific pattern of dysregulated PL, NL, HexCer and oxylipins in ME/CFS patients suggests a possible role of these lipids in promoting immune dysfunction and inflammation which may be among the underlying factors driving the clinical presentation of fatigue, chronic pain, and cognitive difficulties in ill patients."	34454515	CustomKB
HSDN::has_symptom::Disease:Symptom	chronic pain	Symptom	SYMP:0000837	ME/CFS	Disease	MONDO:0005404	"The observed sex-specific pattern of dysregulated PL, NL, HexCer and oxylipins in ME/CFS patients suggests a possible role of these lipids in promoting immune dysfunction and inflammation which may be among the underlying factors driving the clinical presentation of fatigue, chronic pain, and cognitive difficulties in ill patients."	34454515	CustomKB
HSDN::has_symptom::Disease:Symptom	Fatigue	Symptom	SYMP:0019177	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"Fatigue, myalgia, arthralgia and sleep disturbances tend to be more prevalent in the ME/CFS patients compared to the non-ME/CFS patients."	34577881	CustomKB
HSDN::has_symptom::Disease:Symptom	myalgia	Symptom	MESH:D063806	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"Fatigue, myalgia, arthralgia and sleep disturbances tend to be more prevalent in the ME/CFS patients compared to the non-ME/CFS patients."	34577881	CustomKB
HSDN::has_symptom::Disease:Symptom	arthralgia	Symptom	SYMP:0000064	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"Fatigue, myalgia, arthralgia and sleep disturbances tend to be more prevalent in the ME/CFS patients compared to the non-ME/CFS patients."	34577881	CustomKB
HSDN::has_symptom::Disease:Symptom	sleep disturbances	Symptom	SYMP:0000566	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"Fatigue, myalgia, arthralgia and sleep disturbances tend to be more prevalent in the ME/CFS patients compared to the non-ME/CFS patients."	34577881	CustomKB
HSDN::has_symptom::Disease:Symptom	weakness	Symptom	SYMP:0000177	long COVID	Disease	MONDO:0100233	"Over 60 physical and psychological signs and symptoms with wide prevalence were reported, most commonly weakness (41%; 95% CI 25% to 59%), general malaise (33%; 95% CI 15% to 57%), fatigue (31%; 95% CI 24% to 39%), concentration impairment (26%; 95% CI 21% to 32%) and breathlessness (25%; 95% CI 18% to 34%)."	34580069	CustomKB
HSDN::has_symptom::Disease:Symptom	malaise	Symptom	SYMP:0019176	long COVID	Disease	MONDO:0100233	"Over 60 physical and psychological signs and symptoms with wide prevalence were reported, most commonly weakness (41%; 95% CI 25% to 59%), general malaise (33%; 95% CI 15% to 57%), fatigue (31%; 95% CI 24% to 39%), concentration impairment (26%; 95% CI 21% to 32%) and breathlessness (25%; 95% CI 18% to 34%)."	34580069	CustomKB
HSDN::has_symptom::Disease:Symptom	fatigue	Symptom	SYMP:0019177	long COVID	Disease	MONDO:0100233	"Over 60 physical and psychological signs and symptoms with wide prevalence were reported, most commonly weakness (41%; 95% CI 25% to 59%), general malaise (33%; 95% CI 15% to 57%), fatigue (31%; 95% CI 24% to 39%), concentration impairment (26%; 95% CI 21% to 32%) and breathlessness (25%; 95% CI 18% to 34%)."	34580069	CustomKB
HSDN::has_symptom::Disease:Symptom	concentration impairment	Symptom	SYMP:0020029	long COVID	Disease	MONDO:0100233	"Over 60 physical and psychological signs and symptoms with wide prevalence were reported, most commonly weakness (41%; 95% CI 25% to 59%), general malaise (33%; 95% CI 15% to 57%), fatigue (31%; 95% CI 24% to 39%), concentration impairment (26%; 95% CI 21% to 32%) and breathlessness (25%; 95% CI 18% to 34%)."	34580069	CustomKB
HSDN::has_symptom::Disease:Symptom	breathlessness	Symptom	SYMP:0019153	long COVID	Disease	MONDO:0100233	"Over 60 physical and psychological signs and symptoms with wide prevalence were reported, most commonly weakness (41%; 95% CI 25% to 59%), general malaise (33%; 95% CI 15% to 57%), fatigue (31%; 95% CI 24% to 39%), concentration impairment (26%; 95% CI 21% to 32%) and breathlessness (25%; 95% CI 18% to 34%)."	34580069	CustomKB
HSDN::has_symptom::Disease:Symptom	chronic fatigue	Symptom	SYMP:0019177	Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic systemic disease that manifests via various symptoms such as chronic fatigue, post-exertional malaise, and cognitive impairment described as ""brain fog""."	34682909	CustomKB
HSDN::has_symptom::Disease:Symptom	post-exertional malaise	Symptom	SYMP:0019176	Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic systemic disease that manifests via various symptoms such as chronic fatigue, post-exertional malaise, and cognitive impairment described as ""brain fog""."	34682909	CustomKB
HSDN::has_symptom::Disease:Symptom	fatigue	Symptom	SYMP:0019177	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"The most troublesome symptoms included fatigue (85%), pain (65%), cognitive impairment (50%), orthostatic intolerance (45%), sleep disturbance (35%), post-exertional malaise (30%), and neurosensory disturbance (30%)."	34682970	CustomKB
HSDN::has_symptom::Disease:Symptom	pain	Symptom	SYMP:0000099	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"The most troublesome symptoms included fatigue (85%), pain (65%), cognitive impairment (50%), orthostatic intolerance (45%), sleep disturbance (35%), post-exertional malaise (30%), and neurosensory disturbance (30%)."	34682970	CustomKB
HSDN::has_symptom::Disease:Symptom	sleep disturbance	Symptom	SYMP:0000566	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"The most troublesome symptoms included fatigue (85%), pain (65%), cognitive impairment (50%), orthostatic intolerance (45%), sleep disturbance (35%), post-exertional malaise (30%), and neurosensory disturbance (30%)."	34682970	CustomKB
HSDN::has_symptom::Disease:Symptom	post-exertional malaise	Symptom	SYMP:0019176	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"The most troublesome symptoms included fatigue (85%), pain (65%), cognitive impairment (50%), orthostatic intolerance (45%), sleep disturbance (35%), post-exertional malaise (30%), and neurosensory disturbance (30%)."	34682970	CustomKB
HSDN::has_symptom::Disease:Symptom	neurosensory disturbance	Symptom	SYMP:0000336	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"The most troublesome symptoms included fatigue (85%), pain (65%), cognitive impairment (50%), orthostatic intolerance (45%), sleep disturbance (35%), post-exertional malaise (30%), and neurosensory disturbance (30%)."	34682970	CustomKB
HSDN::has_symptom::Disease:Symptom	fatigue	Symptom	SYMP:0019177	long-COVID	Disease	MONDO:0100233	"Original studies supporting each of these subtypes are documented in this review, as well as their respective symptoms and potential interventions."	34888989	CustomKB
HSDN::has_symptom::Disease:Symptom	dyspnoea	Symptom	SYMP:0019153	long-COVID	Disease	MONDO:0100233	"Original studies supporting each of these subtypes are documented in this review, as well as their respective symptoms and potential interventions."	34888989	CustomKB
HSDN::has_symptom::Disease:Symptom	fatigue	Symptom	SYMP:0019177	long COVID	Disease	MONDO:0100233	"The most common 'long COVID' symptoms were fatigue, loss of smell and loss of taste, dizziness, muscle weakness, chest pain and respiratory problems."	35000003	CustomKB
HSDN::has_symptom::Disease:Symptom	loss of smell	Symptom	SYMP:0000551	long COVID	Disease	MONDO:0100233	"The most common 'long COVID' symptoms were fatigue, loss of smell and loss of taste, dizziness, muscle weakness, chest pain and respiratory problems."	35000003	CustomKB
HSDN::has_symptom::Disease:Symptom	loss of taste	Symptom	SYMP:0000551	long COVID	Disease	MONDO:0100233	"The most common 'long COVID' symptoms were fatigue, loss of smell and loss of taste, dizziness, muscle weakness, chest pain and respiratory problems."	35000003	CustomKB
HSDN::has_symptom::Disease:Symptom	dizziness	Symptom	SYMP:0000610	long COVID	Disease	MONDO:0100233	"The most common 'long COVID' symptoms were fatigue, loss of smell and loss of taste, dizziness, muscle weakness, chest pain and respiratory problems."	35000003	CustomKB
HSDN::has_symptom::Disease:Symptom	muscle weakness	Symptom	SYMP:0000094	long COVID	Disease	MONDO:0100233	"The most common 'long COVID' symptoms were fatigue, loss of smell and loss of taste, dizziness, muscle weakness, chest pain and respiratory problems."	35000003	CustomKB
HSDN::has_symptom::Disease:Symptom	chest pain	Symptom	SYMP:0000576	long COVID	Disease	MONDO:0100233	"The most common 'long COVID' symptoms were fatigue, loss of smell and loss of taste, dizziness, muscle weakness, chest pain and respiratory problems."	35000003	CustomKB
HSDN::has_symptom::Disease:Symptom	respiratory problems	Symptom	SYMP:0019153	long COVID	Disease	MONDO:0100233	"The most common 'long COVID' symptoms were fatigue, loss of smell and loss of taste, dizziness, muscle weakness, chest pain and respiratory problems."	35000003	CustomKB
HSDN::has_symptom::Disease:Symptom	fatigue	Symptom	SYMP:0019177	PACS	Disease	MONDO:0100233	"At 6 months, 76% of patients had PACS and the most common symptoms were fatigue, poor memory and hair loss."	35082169	CustomKB
HSDN::has_symptom::Disease:Symptom	poor memory	Symptom	SYMP:0000719	PACS	Disease	MONDO:0100233	"At 6 months, 76% of patients had PACS and the most common symptoms were fatigue, poor memory and hair loss."	35082169	CustomKB
HSDN::has_symptom::Disease:Symptom	hair loss	Symptom	SYMP:0000440	PACS	Disease	MONDO:0100233	"At 6 months, 76% of patients had PACS and the most common symptoms were fatigue, poor memory and hair loss."	35082169	CustomKB
HSDN::has_symptom::Disease:Symptom	fatigue	Symptom	SYMP:0019177	long-haul COVID	Disease	MONDO:0100233	"Clinical symptomatology includes fatigue, malaise, dyspnea, defects in memory and concentration and a variety of neuropsychiatric syndromes as the major manifestations, and several organ systems can be involved."	35105985	CustomKB
HSDN::has_symptom::Disease:Symptom	malaise	Symptom	SYMP:0019176	long-haul COVID	Disease	MONDO:0100233	"Clinical symptomatology includes fatigue, malaise, dyspnea, defects in memory and concentration and a variety of neuropsychiatric syndromes as the major manifestations, and several organ systems can be involved."	35105985	CustomKB
HSDN::has_symptom::Disease:Symptom	dyspnea	Symptom	SYMP:0019153	long-haul COVID	Disease	MONDO:0100233	"Clinical symptomatology includes fatigue, malaise, dyspnea, defects in memory and concentration and a variety of neuropsychiatric syndromes as the major manifestations, and several organ systems can be involved."	35105985	CustomKB
HSDN::has_symptom::Disease:Symptom	fatigue	Symptom	SYMP:0019177	long COVID	Disease	MONDO:0100233	"Common symptoms of the post-COVID-19 condition include, but are not limited to, fatigue, shortness of breath, and cognitive dysfunction."	35287333	CustomKB
HSDN::has_symptom::Disease:Symptom	shortness of breath	Symptom	SYMP:0019153	long COVID	Disease	MONDO:0100233	"Common symptoms of the post-COVID-19 condition include, but are not limited to, fatigue, shortness of breath, and cognitive dysfunction."	35287333	CustomKB
HSDN::has_symptom::Disease:Symptom	profound fatigue	Symptom	SYMP:0019177	ME/CFS	Disease	MONDO:0005404	"with symptoms that overlap with conditions like ME/CFS (profound fatigue, unrefreshing sleep, post-exertional malaise, cognitive dysfunction, and orthostatic intolerance)."	35287333	CustomKB
HSDN::has_symptom::Disease:Symptom	unrefreshing sleep	Symptom	SYMP:0000566	ME/CFS	Disease	MONDO:0005404	"with symptoms that overlap with conditions like ME/CFS (profound fatigue, unrefreshing sleep, post-exertional malaise, cognitive dysfunction, and orthostatic intolerance)."	35287333	CustomKB
HSDN::has_symptom::Disease:Symptom	post-exertional malaise	Symptom	SYMP:0019176	ME/CFS	Disease	MONDO:0005404	"with symptoms that overlap with conditions like ME/CFS (profound fatigue, unrefreshing sleep, post-exertional malaise, cognitive dysfunction, and orthostatic intolerance)."	35287333	CustomKB
HSDN::has_symptom::Disease:Symptom	orthostatic intolerance	Symptom	MESH:D054971	ME/CFS	Disease	MONDO:0005404	"with symptoms that overlap with conditions like ME/CFS (profound fatigue, unrefreshing sleep, post-exertional malaise, cognitive dysfunction, and orthostatic intolerance)."	35287333	CustomKB
HSDN::has_symptom::Disease:Symptom	stomach pain	Symptom	MESH:D015746	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"From analyses using receiver operating characteristic statistics, the students who had had severe gastrointestinal symptoms of stomach pain, bloating, and an irritable bowel at baseline and who also had abnormally low levels of the immune markers IL-13 and/or IL-5 at baseline, as well as severe gastrointestinal symptoms when then contracted IM, were found to have a nearly 80% chance of having severe ME/CFS persisting six months following IM."	35350440	CustomKB
HSDN::has_symptom::Disease:Symptom	bloating	Symptom	SYMP:0000420	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"From analyses using receiver operating characteristic statistics, the students who had had severe gastrointestinal symptoms of stomach pain, bloating, and an irritable bowel at baseline and who also had abnormally low levels of the immune markers IL-13 and/or IL-5 at baseline, as well as severe gastrointestinal symptoms when then contracted IM, were found to have a nearly 80% chance of having severe ME/CFS persisting six months following IM."	35350440	CustomKB
HSDN::has_symptom::Disease:Symptom	Post-exertional malaise (PEM)	Symptom	SYMP:0019176	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	Post-exertional malaise (PEM) is a hallmark symptom of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).	35358096	CustomKB
HSDN::has_symptom::Disease:Symptom	fatigue	Symptom	SYMP:0019177	long-term post-COVID	Disease	MONDO:0100233	"Patients exhibiting post-COVID fatigue at 6 or 12 months exhibited a lower hemoglobin level, higher lymphocyte count, and lower neutrophil and platelets counts (all, p < 0.05), whereas those exhibiting post-COVID dyspnea at 6 or 12 months had a lower platelet count and lower alanine transaminase, aspartate transaminase, and lactate dehydrogenase (LDH) levels (all, p < 0.05) than those not developing post-COVID fatigue or dyspnea, respectively."	35381597	CustomKB
HSDN::has_symptom::Disease:Symptom	dyspnea	Symptom	SYMP:0019153	long-term post-COVID	Disease	MONDO:0100233	"Patients exhibiting post-COVID fatigue at 6 or 12 months exhibited a lower hemoglobin level, higher lymphocyte count, and lower neutrophil and platelets counts (all, p < 0.05), whereas those exhibiting post-COVID dyspnea at 6 or 12 months had a lower platelet count and lower alanine transaminase, aspartate transaminase, and lactate dehydrogenase (LDH) levels (all, p < 0.05) than those not developing post-COVID fatigue or dyspnea, respectively."	35381597	CustomKB
HSDN::has_symptom::Disease:Symptom	loss of taste/smell	Symptom	SYMP:0000551	post COVID-19 disease	Disease	MONDO:0100233	"Evolution of symptoms showed a decreasing prevalence over time for 27/53 symptoms (e.g., loss of taste/smell); a stable prevalence over time for 18/53 symptoms (e.g., dyspnoea), and an increasing prevalence over time for 8/53 symptoms (e.g., paraesthesia)."	35383197	CustomKB
HSDN::has_symptom::Disease:Symptom	dyspnoea	Symptom	SYMP:0019153	post COVID-19 disease	Disease	MONDO:0100233	"Evolution of symptoms showed a decreasing prevalence over time for 27/53 symptoms (e.g., loss of taste/smell); a stable prevalence over time for 18/53 symptoms (e.g., dyspnoea), and an increasing prevalence over time for 8/53 symptoms (e.g., paraesthesia)."	35383197	CustomKB
HSDN::has_symptom::Disease:Symptom	paraesthesia	Symptom	MESH:D010292	post COVID-19 disease	Disease	MONDO:0100233	"Evolution of symptoms showed a decreasing prevalence over time for 27/53 symptoms (e.g., loss of taste/smell); a stable prevalence over time for 18/53 symptoms (e.g., dyspnoea), and an increasing prevalence over time for 8/53 symptoms (e.g., paraesthesia)."	35383197	CustomKB
HSDN::has_symptom::Disease:Symptom	chronic hypoxia	Symptom	MESH:D005311	long COVID	Disease	MONDO:0100233	"Possible pathophysiological mechanisms of long COVID include: persistent viral replication, chronic hypoxia and inflammation."	35449732	CustomKB
HSDN::has_symptom::Disease:Symptom	insomnia	Symptom	SYMP:0000571	ME/CFS	Disease	MONDO:0005404	"We propose that disrupted TGFB signaling in ME/CFS may play a role in disrupting physiological rhythms in sleep, activity, and cognition, leading to the insomnia, energy disturbances, cognition problems, depression, and autonomic dysfunction associated with ME/CFS."	35465246	CustomKB
HSDN::has_symptom::Disease:Symptom	depression	Symptom	SYMP:0000022	ME/CFS	Disease	MONDO:0005404	"We propose that disrupted TGFB signaling in ME/CFS may play a role in disrupting physiological rhythms in sleep, activity, and cognition, leading to the insomnia, energy disturbances, cognition problems, depression, and autonomic dysfunction associated with ME/CFS."	35465246	CustomKB
HSDN::has_symptom::Disease:Symptom	fatigue	Symptom	SYMP:0019177	ME/CFS	Disease	MONDO:0005404	"Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is characterized by unexplained debilitating fatigue, cognitive dysfunction, gastrointestinal disturbances, and orthostatic intolerance."	36758522	CustomKB
HSDN::has_symptom::Disease:Symptom	acute exercise intolerance	Symptom	SYMP:0019176	ME/CFS	Disease	MONDO:0005404	We suggest that treatable neurovascular dysregulation underlies acute exercise intolerance in ME/CFS.	35526605	CustomKB
HSDN::has_symptom::Disease:Symptom	post exertional malaise	Symptom	SYMP:0019176	post-acute sequelae COVID	Disease	MONDO:0100233	"Because the two key features - post exertional malaise and decreased cerebral blood flow - are also recognized in a subset of patients with post-acute sequelae COVID, we suggest that our findings may also be pertinent to this entity."	35614970	CustomKB
HSDN::has_symptom::Disease:Symptom	neuroinflammation	Symptom	MESH:D020078	"chronic fatigue syndrome, or myalgic encephalomyelitis (CFS/ME)"	Disease	MONDO:0005404	"Many diseases, such as gastrointestinal inflammation, chronic obstructive pulmonary disease, rheumatoid arthritis, dermatitis, chronic fatigue syndrome, or myalgic encephalomyelitis (CFS/ME), trigger neuroinflammation through several pathways."	35783147	CustomKB
HSDN::has_symptom::Disease:Symptom	fatigue	Symptom	SYMP:0019177	Post-COVID syndrome (PCS)	Disease	MONDO:0100233	"Neurological ailments (61·5%), fatigue (57·1%), and sleep disturbance (57·0%) were the most frequent persisting symptoms at 6-12 months after infection."	35875815	CustomKB
HSDN::has_symptom::Disease:Symptom	sleep disturbance	Symptom	SYMP:0000566	Post-COVID syndrome (PCS)	Disease	MONDO:0100233	"Neurological ailments (61·5%), fatigue (57·1%), and sleep disturbance (57·0%) were the most frequent persisting symptoms at 6-12 months after infection."	35875815	CustomKB
INTACT::ASSOCIATION::Compound:Gene	B2M	Gene	ENTREZ:567	Dexamethasone	Compound	DrugBank:DB01234	TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	SERPINE1	Gene	ENTREZ:5054	Dexamethasone	Compound	DrugBank:DB01234	TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	EGF	Gene	ENTREZ:1950	Dexamethasone	Compound	DrugBank:DB01234	TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	BCL2	Gene	ENTREZ:596	Dexamethasone	Compound	DrugBank:DB01234	 TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	S100A9	Gene	ENTREZ:6280	Dexamethasone	Compound	DrugBank:DB01234	TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	S100A8	Gene	ENTREZ:6279	Dexamethasone	Compound	DrugBank:DB01234	TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	SERPINE1	Gene	ENTREZ:5054	Palmitic Acid	Compound	DrugBank:DB03796	TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	BCL2	Gene	ENTREZ:596	Palmitic Acid	Compound	DrugBank:DB03796	TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	SOD1	Gene	ENTREZ:6647	Palmitic Acid	Compound	DrugBank:DB03796	TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	CXCL8	Gene	ENTREZ:3576	Calcium	Compound	DrugBank:DB01373	TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	EGF	Gene	ENTREZ:1950	Calcium	Compound	DrugBank:DB01373	TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	SOD1	Gene	ENTREZ:6647	Calcium	Compound	DrugBank:DB01373	TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	S100A9	Gene	ENTREZ:6280	Calcium	Compound	DrugBank:DB01373	TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	S100A8	Gene	ENTREZ:6279	Calcium	Compound	DrugBank:DB01373	 TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	CXCL8	Gene	ENTREZ:3576	Copper	Compound	DrugBank:DB09130	TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	EGF	Gene	ENTREZ:1950	Copper	Compound	DrugBank:DB09130	 TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	SERPINE1	Gene	ENTREZ:5054	Copper	Compound	DrugBank:DB09130	TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	BCL2	Gene	ENTREZ:596	Copper	Compound	DrugBank:DB09130	TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	HMGB1	Gene	ENTREZ:3146	Copper	Compound	DrugBank:DB09130	TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	B2M	Gene	ENTREZ:567	Copper	Compound	DrugBank:DB09130	 TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	S100A8	Gene	ENTREZ:6279	Copper	Compound	DrugBank:DB09130	TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	SOD1	Gene	ENTREZ:6647	Copper	Compound	DrugBank:DB09130	TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	CXCL8	Gene	ENTREZ:3576	Silver	Compound	DrugBank:DB12965	TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	SERPINE1	Gene	ENTREZ:5054	Silver	Compound	DrugBank:DB12965	TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	BCL2	Gene	ENTREZ:596	Silver	Compound	DrugBank:DB12965	 TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::ASSOCIATION::Compound:Gene	SOD1	Gene	ENTREZ:6647	Silver	Compound	DrugBank:DB12965	TABLE 6 Prediction of top 10 candidate drugs for Long COVID and ME/CFS.	36189286	CustomKB
INTACT::CLEAVAGE REACTION::Gene:Gene	elastase	Gene	ENTREZ:1991	83 kDa RNase L	Gene	ENTREZ:6041	"The 2-5A synthetase/RNase L pathway in CFS patients appears to be both up-regulated (i.e. increased levels of bioactive 2-5A synthetase and increased activity of the RNase L enzyme) and deregulated (elastase and calpain initiate 83 kDa RNase L proteolysis, generating two major fragments with molecular masses of 37 and 30 kDa, respectively)."	16277015	CustomKB
INTACT::CLEAVAGE REACTION::Gene:Gene	calpain	Gene	ENTREZ:823	83 kDa RNase L	Gene	ENTREZ:6041	"The 2-5A synthetase/RNase L pathway in CFS patients appears to be both up-regulated (i.e. increased levels of bioactive 2-5A synthetase and increased activity of the RNase L enzyme) and deregulated (elastase and calpain initiate 83 kDa RNase L proteolysis, generating two major fragments with molecular masses of 37 and 30 kDa, respectively)."	16277015	CustomKB
PrimeKG::associated_with::Gene:Disease	CD56(bright) NK receptors	Gene	ENTREZ:4684	CFS/ME	Disease	MONDO:0005404	"Over time, iNKT CD62L expression significantly increased in moderate CFS/ME patients and CD56(bright) NK receptors differed in severe CFS/ME."	26370228	CustomKB
PrimeKG::associated_with:Gene:Disease	CD26	Gene	ENTREZ:1803	ME/CFS	Disease	MONDO:0005404	"In ME/CFS patients, severe alterations of the muscle excitability, the redox status, as well as the CD26-expression level are correlated with a marked impairment of the quality-of-life."	27580693	CustomKB
PrimeKG::associated_with:Gene:Disease	pyruvate dehydrogenase	Gene	ENTREZ:5160	Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"They exhibited proteome alterations, including altered mitochondrial metabolism, centred on pyruvate dehydrogenase and coenzyme A metabolism, leading to a decreased capacity to provide adequate intracellular ATP levels."	34209852	CustomKB
PrimeKG::associated_with:Gene:Disease	TPPP	Gene	ENTREZ:11076	Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	"In the Norwegian discovery cohort, the TPPP gene region showed the most significant association (rs115523291, P = 8.5 × 10-7), but we could not replicate the top SNP."	35318112	CustomKB
PrimeKG::associated_with:Gene:Disease	HLA-C	Gene	ENTREZ:3107	ME/CFS	Disease	MONDO:0005404	We recently reported an association with the immunologically important human leucocyte antigen (HLA) genes HLA-C and HLA-DQB1 in ME/CFS.	35821115	CustomKB
PrimeKG::associated_with:Gene:Disease	HLA-DQB1	Gene	ENTREZ:3119	ME/CFS	Disease	MONDO:0005404	We recently reported an association with the immunologically important human leucocyte antigen (HLA) genes HLA-C and HLA-DQB1 in ME/CFS.	35821115	CustomKB
PrimeKG::expression_present:Gene:Anatomy	TPPP	Gene	ENTREZ:11076	brain	Anatomy	MESH:D001921	"Interestingly, TPPP is expressed in brain tissues, hence it will be interesting to see whether this association, with time, will be verified in even larger cohorts."	35318112	CustomKB
PrimeKG::interacts_with::Pathway:Gene	p38 MAPK regulatory pathway	Pathway	KEGG:hsa_M00689	WASF3	Gene	ENTREZ:10810	"In particular, the gene WASF3 (aka WAVE3) possibly regulates brain cytokines involved in the mechanism of fatigue through the p38 MAPK regulatory pathway."	21584188	CustomKB
PrimeKG::parent-child:BiologicalProcess:BiologicalProcess	natural killer (NK) cell cytotoxic function	BiologicalProcess	GO:0042267	calcium (Ca2+) influx	BiologicalProcess	GO:0070509	NK cell effector functions rely on long-term sustained calcium (Ca2+) influx.	35172836	CustomKB
PrimeKG::parent-child:Disease:Disease	COVID-19	Disease	MONDO:0100096	myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	ME/CFS can be triggered by COVID-19 in adolescents and young adults.	33996867	CustomKB
PrimeKG::parent-child:Disease:Disease	pulmonary fibrosis sequelae (PFS)	Disease	MONDO:0002771	long-COVID	Disease	MONDO:0100233	"The subtypes are non-severe COVID-19 multi-organ sequelae (NSC-MOS), pulmonary fibrosis sequelae (PFS), myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS), postural orthostatic tachycardia syndrome (POTS), post-intensive care syndrome (PICS) and medical or clinical sequelae (MCS)."	34888989	CustomKB
PrimeKG::parent-child:Disease:Disease	myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS)	Disease	MONDO:0005404	long-COVID	Disease	MONDO:0100233	"The subtypes are non-severe COVID-19 multi-organ sequelae (NSC-MOS), pulmonary fibrosis sequelae (PFS), myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS), postural orthostatic tachycardia syndrome (POTS), post-intensive care syndrome (PICS) and medical or clinical sequelae (MCS)."	34888989	CustomKB
PrimeKG::parent-child:Disease:Disease	postural orthostatic tachycardia syndrome (POTS)	Disease	MONDO:0011479	long-COVID	Disease	MONDO:0100233	"The subtypes are non-severe COVID-19 multi-organ sequelae (NSC-MOS), pulmonary fibrosis sequelae (PFS), myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS), postural orthostatic tachycardia syndrome (POTS), post-intensive care syndrome (PICS) and medical or clinical sequelae (MCS)."	34888989	CustomKB
PrimeKG::parent-child:Disease:Disease	post-intensive care syndrome (PICS)	Disease	MESH:C000711429	long-COVID	Disease	MONDO:0100233	"The subtypes are non-severe COVID-19 multi-organ sequelae (NSC-MOS), pulmonary fibrosis sequelae (PFS), myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS), postural orthostatic tachycardia syndrome (POTS), post-intensive care syndrome (PICS) and medical or clinical sequelae (MCS)."	34888989	CustomKB
PrimeKG::parent-child:Disease:Disease	ME/CFS	Disease	MONDO:0005404	Ischaemia-reperfusion (I-R) injury	Disease	MONDO:0005203	"We argue here that I-R injury also underpins elements of the pathology of a variety of chronic, inflammatory diseases, including rheumatoid arthritis, ME/CFS and, our chief focus and most proximally, Long COVID."	36043493	CustomKB
PrimeKG::parent-child:Disease:Disease	Long COVID	Disease	MONDO:0100233	Ischaemia-reperfusion (I-R) injury	Disease	MONDO:0005203	"We argue here that I-R injury also underpins elements of the pathology of a variety of chronic, inflammatory diseases, including rheumatoid arthritis, ME/CFS and, our chief focus and most proximally, Long COVID."	36043493	CustomKB
